{"meta":{"query_hash":"a3c27dcb627f","filters":{"venue":"Cancer Treatment and Research Communications"},"cohort_total":49,"direct_labels_cover":0,"predictions_cover":49,"exported":49,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a3c27dcb627f","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cancer+Treatment+and+Research+Communications"},"results":[{"id":"W2543318099","doi":"10.1016/j.ctarc.2016.10.001","title":"The role of education in colorectal cancer screening participation: Updated evidence from Canadian Community Health Survey (2011–2012)","year":2016,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Sigmoidoscopy; Medicine; Graduation (instrument); Colorectal cancer; Fecal occult blood; Psychological intervention; Context (archaeology); Colonoscopy; Logistic regression; Odds; Odds ratio; Family medicine; Demography; Cancer; Gerontology; Internal medicine; Nursing","score_opus":0.1935098833369035,"score_gpt":0.47111156786995706,"score_spread":0.27760168453305356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2543318099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9323603,0.055893775,0.0000145733875,0.010508564,0.000060777656,0.0006203047,0.00018046673,0.000015992442,0.00034522524],"genre_scores_gemma":[0.9589544,0.03965967,0.00011488003,0.000032907774,0.00003689952,0.0007234504,0.00010062195,0.000010746223,0.00036640125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99745417,0.0015980847,0.0002651294,0.00016224447,0.00020057047,0.0003198059],"domain_scores_gemma":[0.99660486,0.0018059884,0.00009383073,0.0007458568,0.00048780488,0.00026163514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014706663,0.00009886149,0.00019769832,0.00019140489,0.0010364226,0.000030903095,0.0002685381,0.000060893428,0.00008816356],"category_scores_gemma":[0.00023428453,0.000060668495,0.00003133438,0.0004145959,0.00041869195,0.00014179487,0.00010933368,0.0003002912,0.0000038930866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061530666,0.00012118097,0.5429898,0.000004239571,0.00005969146,8.739672e-8,0.0009795781,0.0000018525274,0.0009468746,0.00003812014,0.0004577438,0.4537855],"study_design_scores_gemma":[0.00060723326,0.00068085385,0.9880476,0.0005094752,0.000020337007,8.2118225e-7,0.000880466,0.0002509845,0.0025097283,0.0001656123,0.006263049,0.0000638293],"about_ca_topic_score_codex":0.95794344,"about_ca_topic_score_gemma":0.99111974,"teacher_disagreement_score":0.4537217,"about_ca_system_score_codex":0.0014155055,"about_ca_system_score_gemma":0.0038690665,"threshold_uncertainty_score":0.79714286},"labels":[],"label_agreement":null},{"id":"W2594051854","doi":"10.1016/j.ctarc.2017.02.005","title":"Challenging the Paradigm: EGFR wild-type benefit from an EGFR inhibitor in NSCLC","year":2017,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; BC Research (Canada); BC Cancer Agency","funders":"Boehringer Ingelheim; AstraZeneca","keywords":"Afatinib; Erlotinib; Gefitinib; Epidermal growth factor receptor; Lung cancer; Medicine; Erlotinib Hydrochloride; Oncology; EGFR inhibitors; Tyrosine kinase; Internal medicine; Cancer research; Cancer; Receptor","score_opus":0.16822991829360176,"score_gpt":0.49793433245532476,"score_spread":0.329704414161723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594051854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8528196,0.03947805,0.0000027697595,0.095616736,0.00013832976,0.0012329428,0.00009085634,0.00003905555,0.01058166],"genre_scores_gemma":[0.9533739,0.043812215,0.00019237502,0.00009507071,0.00017504892,0.00066117547,0.00016206157,0.000021068034,0.0015070502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890167,0.00012235115,0.00017636946,0.00027727443,0.00020932582,0.00031298568],"domain_scores_gemma":[0.99692416,0.00026491785,0.00006378553,0.0024253735,0.00014544024,0.00017632481],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00022619759,0.000143176,0.00021267017,0.00011985709,0.0020581174,0.0001811593,0.00049704785,0.00007035794,0.0000657687],"category_scores_gemma":[0.000048621077,0.0000894626,0.000047546713,0.0001491607,0.00050411525,0.00023044538,0.00021873621,0.00028699942,0.000016476673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005209004,0.0032352917,0.5022776,0.000043965032,0.0014918095,0.000050014107,0.025603862,0.00004698091,0.0011060213,0.02390814,0.0012542957,0.4404611],"study_design_scores_gemma":[0.0067548114,0.0010626053,0.8590473,0.00062729197,0.00042843804,0.0000085858555,0.0036853098,0.0016597481,0.00046762067,0.004979526,0.121007845,0.00027090675],"about_ca_topic_score_codex":0.021279413,"about_ca_topic_score_gemma":0.01554828,"teacher_disagreement_score":0.4401902,"about_ca_system_score_codex":0.0006419011,"about_ca_system_score_gemma":0.00038071518,"threshold_uncertainty_score":0.99924105},"labels":[],"label_agreement":null},{"id":"W2620604883","doi":"10.1016/j.ctarc.2017.06.002","title":"The influence of season and distance to a cancer centre on lung cancer treatment rates","year":2017,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Lung cancer; Cancer; Medicine; Oncology; Internal medicine; Demography; Sociology","score_opus":0.08108672179372736,"score_gpt":0.5047361230608941,"score_spread":0.42364940126716677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620604883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8793865,0.051923797,0.0000014294252,0.06484764,0.000057408597,0.0016997395,0.00037549628,0.000018365194,0.0016896562],"genre_scores_gemma":[0.81019133,0.18030408,0.00008280606,0.00006765434,0.000051607713,0.002391984,0.000018190498,0.00001791869,0.0068744346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874836,0.00011754598,0.00019691348,0.00032111106,0.00025072362,0.00036536183],"domain_scores_gemma":[0.9971281,0.0004187511,0.000116809286,0.0016550327,0.00040462447,0.00027662574],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00014405974,0.00019879067,0.00028314107,0.00008482124,0.002488215,0.00015501937,0.00033485878,0.000050867977,0.000026449781],"category_scores_gemma":[0.00007836861,0.00011336607,0.000059214064,0.000156242,0.0007430632,0.000112527436,0.00017924339,0.0001345183,0.0000026789403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065947516,0.0008854299,0.7579848,0.000111277004,0.0016685675,0.0000075463313,0.0073539643,0.00016865753,0.0011791288,0.0044970573,0.0017035467,0.22378054],"study_design_scores_gemma":[0.004362545,0.001056023,0.8355269,0.0013726436,0.0007127333,0.0000026128448,0.0010655607,0.00059710315,0.002606182,0.00015672135,0.1523188,0.00022221093],"about_ca_topic_score_codex":0.019084105,"about_ca_topic_score_gemma":0.022928009,"teacher_disagreement_score":0.22355832,"about_ca_system_score_codex":0.0011355997,"about_ca_system_score_gemma":0.00065861543,"threshold_uncertainty_score":0.9988104},"labels":[],"label_agreement":null},{"id":"W2790018618","doi":"10.1016/j.ctarc.2018.02.002","title":"Benefit of crizotinib in a lung cancer patient with discordant ALK testing results","year":2018,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Crizotinib; Medicine; Lung cancer; Anaplastic lymphoma kinase; Oncology; Pleural effusion; Internal medicine; Radiology; Pathology; Malignant pleural effusion","score_opus":0.12461204940114946,"score_gpt":0.47865714152750405,"score_spread":0.3540450921263546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790018618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9521034,0.013450066,0.0000062365134,0.008276833,0.000038783317,0.0014651744,0.0002728275,0.000026439146,0.024360277],"genre_scores_gemma":[0.9885799,0.006559814,0.0025024342,0.00003400962,0.000047923,0.0012884911,0.000065816945,0.00001897275,0.0009026035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988454,0.00007981517,0.00028342538,0.00026019942,0.00023493827,0.00029619652],"domain_scores_gemma":[0.99802536,0.00032999553,0.00008951586,0.00082359806,0.00059911073,0.00013242313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014837291,0.00013168252,0.00023886244,0.0002200338,0.00035483495,0.00002239265,0.0001415845,0.00002669987,0.000024921159],"category_scores_gemma":[0.000063372914,0.00008393833,0.000029501605,0.00069850317,0.00058241416,0.000080167745,0.00012292663,0.00015243441,0.0000014615352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026861853,0.0039434014,0.55408823,0.0002919459,0.0015449214,0.00006856331,0.026015123,0.00008870682,0.0035157157,0.0023046662,0.00090746966,0.4045451],"study_design_scores_gemma":[0.040608846,0.021440513,0.8120049,0.011228658,0.002189529,0.00015341504,0.012500719,0.010911151,0.019662451,0.0007988914,0.06748567,0.0010152486],"about_ca_topic_score_codex":0.016436633,"about_ca_topic_score_gemma":0.0145460535,"teacher_disagreement_score":0.40352982,"about_ca_system_score_codex":0.00059993885,"about_ca_system_score_gemma":0.00068443565,"threshold_uncertainty_score":0.990113},"labels":[],"label_agreement":null},{"id":"W2923839935","doi":"10.1016/j.ctarc.2019.100130","title":"Inpatients versus outpatients with advanced non-small cell lung cancer: Characteristics and outcomes","year":2019,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Lung cancer; Medicine; Oncology; Cancer; Internal medicine; Intensive care medicine","score_opus":0.051103386016498616,"score_gpt":0.42214878576659487,"score_spread":0.37104539975009626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923839935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98446727,0.0068661436,0.0000039977717,0.0020847302,0.00013696533,0.0019616934,0.00018706419,0.00002860753,0.0042635123],"genre_scores_gemma":[0.9663943,0.026404712,0.00082619686,0.00006038579,0.000022324946,0.0014795866,0.00022158577,0.00003128954,0.004559625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884856,0.00006618109,0.00019079846,0.0003212206,0.00023734193,0.00033588763],"domain_scores_gemma":[0.9982514,0.00023777325,0.000083676045,0.0008715814,0.00032649792,0.00022907465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007158137,0.0002008376,0.0003252793,0.00015749448,0.00042742092,0.000053566597,0.00015600848,0.00006041757,0.000057897345],"category_scores_gemma":[0.0000125809665,0.0001341889,0.000040242783,0.00023738397,0.00020694776,0.00011613545,0.00016475565,0.00020250867,0.000010178579],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043469112,0.00057824614,0.9582343,0.00012155368,0.000504003,0.000002645635,0.0024912197,0.0000037886036,0.00015947672,0.00006556133,0.00007530445,0.037329182],"study_design_scores_gemma":[0.023124967,0.0034973999,0.9520183,0.000596086,0.00092258764,0.0000025390286,0.0016138545,0.0007903683,0.00045361422,0.000012030253,0.01665037,0.00031787637],"about_ca_topic_score_codex":0.0013232002,"about_ca_topic_score_gemma":0.0005640536,"teacher_disagreement_score":0.037011303,"about_ca_system_score_codex":0.0006145209,"about_ca_system_score_gemma":0.0004811981,"threshold_uncertainty_score":0.54720646},"labels":[],"label_agreement":null},{"id":"W2972810294","doi":"10.1016/j.ctarc.2019.100160","title":"Adherence to guidelines for baseline staging in newly diagnosed localized breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Essar Steel Algoma (Canada); Sault Area Hospital; NOSM University","funders":"","keywords":"Medicine; Breast cancer; Guideline; Cancer; Stage (stratigraphy); Cancer staging; Retrospective cohort study; Cohort; Internal medicine","score_opus":0.16547276914503498,"score_gpt":0.47950190672669807,"score_spread":0.31402913758166306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972810294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88057464,0.049322937,0.00034079474,0.06370788,0.0001939824,0.003436433,0.0018811625,0.000033732584,0.0005084521],"genre_scores_gemma":[0.93870366,0.049958885,0.0029336943,0.00045942003,0.00016488727,0.0058657527,0.00024980336,0.0000315079,0.0016324148],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871725,0.0001543233,0.00023029992,0.0003969285,0.00013189869,0.00036929158],"domain_scores_gemma":[0.9981101,0.00021268203,0.000040566283,0.00087483466,0.0006414017,0.00012042457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034943025,0.00017028929,0.00022015964,0.00011918245,0.00023664397,0.000036096582,0.00035004996,0.00006317188,0.00005744274],"category_scores_gemma":[0.00010589737,0.00013617185,0.0000571352,0.000273885,0.00014382531,0.000008949107,0.0003308599,0.00008056802,0.000007260703],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012483773,0.0008329174,0.617271,0.00010155684,0.00056326535,0.0000021925568,0.0013375068,0.0007387026,0.025484798,0.00036902365,0.018038105,0.33401254],"study_design_scores_gemma":[0.026424319,0.0023061612,0.25048447,0.0013440555,0.00021522351,0.000009585896,0.005009943,0.0039377757,0.015827293,0.00043765167,0.6926933,0.0013102411],"about_ca_topic_score_codex":0.009282548,"about_ca_topic_score_gemma":0.0146766,"teacher_disagreement_score":0.6746552,"about_ca_system_score_codex":0.00024740805,"about_ca_system_score_gemma":0.0003255701,"threshold_uncertainty_score":0.99731475},"labels":[],"label_agreement":null},{"id":"W3025767822","doi":"10.1016/j.ctarc.2020.100178","title":"Salivary gland-type mammary carcinoma arising in microglandular adenosis: A case report and clinicopathological review of the literature","year":2020,"lang":"en","type":"review","venue":"Cancer Treatment and Research Communications","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick; University Health Network; Canada Research Chairs; University of Toronto; Sunnybrook Health Science Centre","funders":"Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Salivary gland; Mammary gland; Pathology; Myoepithelial cell; Carcinoma; Biopsy; Breast carcinoma; Radiation therapy; Oncology; Breast cancer; Cancer; Radiology; Internal medicine; Immunohistochemistry","score_opus":0.23925899124303776,"score_gpt":0.4932121560949287,"score_spread":0.2539531648518909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025767822","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021501938,0.9900993,1.0860602e-7,0.00506233,0.000046952817,0.0022541329,0.00013826603,0.000013389452,0.00023533893],"genre_scores_gemma":[0.009866926,0.988218,0.00021889621,0.00011983325,0.00006825853,0.000929186,0.0004385892,0.00002667311,0.00011363251],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970641,0.0012131856,0.0007539516,0.00048723965,0.00022419295,0.0002573291],"domain_scores_gemma":[0.9967806,0.00077319186,0.00025633597,0.0017846719,0.00021603258,0.0001891845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066228374,0.0003245844,0.0015684235,0.0001839785,0.00026088906,0.000048560905,0.00031479582,0.00022528229,0.000011929588],"category_scores_gemma":[0.0002735998,0.00016609886,0.0002999615,0.0009784288,0.00034323035,0.00004740947,0.00063495815,0.0008185828,0.0000014487391],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075962154,0.0017964657,0.14869598,0.075863555,0.00074931653,0.08419326,0.0010973347,1.2842292e-8,7.1444265e-7,0.00026991515,0.0012345879,0.6860229],"study_design_scores_gemma":[0.0015557144,0.00082152657,0.009538044,0.24041371,0.0028817947,0.073154144,0.00007725275,0.0000040170767,0.0000041655944,0.00006515289,0.6712198,0.0002646596],"about_ca_topic_score_codex":0.00043775645,"about_ca_topic_score_gemma":0.000081499085,"teacher_disagreement_score":0.68575823,"about_ca_system_score_codex":0.00028242264,"about_ca_system_score_gemma":0.00078251294,"threshold_uncertainty_score":0.6773315},"labels":[],"label_agreement":null},{"id":"W3036878031","doi":"10.1016/j.ctarc.2020.100185","title":"The impact of smoking on adjuvant breast cancer radiation treatment: A systematic review","year":2020,"lang":"en","type":"review","venue":"Cancer Treatment and Research Communications","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Breast cancer; Radiation therapy; Internal medicine; Smoking cessation; MEDLINE; Adjuvant radiotherapy; Cancer; Quality of life (healthcare); Systematic review; Adjuvant; Oncology; Pathology","score_opus":0.13500641669959385,"score_gpt":0.49302904008085136,"score_spread":0.3580226233812575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036878031","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001676376,0.9931566,4.153354e-7,0.0015567867,0.00004163293,0.0032698947,0.0017446463,0.000012269111,0.00020095879],"genre_scores_gemma":[0.0015447908,0.9868758,0.0000054771986,0.000017514369,0.00014705004,0.010542101,0.00053112395,0.00005691087,0.00027927788],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971208,0.0011582905,0.0006087699,0.00047188735,0.00025409143,0.0003861854],"domain_scores_gemma":[0.9965358,0.0005988063,0.00046361572,0.0019768851,0.00027430087,0.00015062054],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031465472,0.0005101176,0.0016384879,0.0001076416,0.00079651724,0.000058182894,0.00070836814,0.0001544555,0.000012354857],"category_scores_gemma":[0.000099189136,0.0002508234,0.00070073764,0.00045448804,0.00044904614,0.000006622719,0.00031393126,0.00021733716,0.0000067710534],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005639912,0.00034092393,0.00015396577,0.06161366,0.007339212,0.0000018350203,0.00016741808,0.0000017174506,0.0000035469247,0.00006866608,0.0010450884,0.92920756],"study_design_scores_gemma":[0.0013204673,0.0014763252,0.00035837453,0.29732874,0.0077596093,0.00004622049,0.000113074886,0.000014360892,0.000021101507,0.000017646562,0.69102234,0.0005217091],"about_ca_topic_score_codex":0.0019636173,"about_ca_topic_score_gemma":0.00042966218,"teacher_disagreement_score":0.92868584,"about_ca_system_score_codex":0.001557208,"about_ca_system_score_gemma":0.0013191514,"threshold_uncertainty_score":0.9999944},"labels":[],"label_agreement":null},{"id":"W3097450343","doi":"10.1016/j.ctarc.2020.100233","title":"Nutritional outcomes in head and neck cancer patients: is intensive nutritional care worth it?","year":2020,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Head and neck cancer; Medicine; Head and neck; Intensive care medicine; Head (geology); Cancer; Gerontology; Internal medicine; Surgery","score_opus":0.25699926979951065,"score_gpt":0.5041243990798802,"score_spread":0.2471251292803695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097450343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5996259,0.035539553,8.9267223e-7,0.3623246,0.00002993074,0.0010085616,0.0005902272,0.000022290655,0.0008580515],"genre_scores_gemma":[0.88836575,0.10186553,0.0007035323,0.007207775,0.000083408355,0.0011435654,0.00040115463,0.000013892387,0.00021540528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988806,0.00011217824,0.00023918314,0.00025247966,0.00025432737,0.0002612298],"domain_scores_gemma":[0.9982832,0.00022419849,0.000035002933,0.00027975664,0.0008745905,0.00030323575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006636814,0.00012108836,0.00026895117,0.0001790567,0.00040800788,0.00003353809,0.00011146338,0.00006321744,0.00019441056],"category_scores_gemma":[0.0000683017,0.00010054666,0.00004529757,0.00031812795,0.00031978852,0.00008582334,0.00013726336,0.000350532,0.000006914502],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021085913,0.0006340383,0.9804856,0.00028014003,0.00007423289,0.000004196188,0.0061181937,2.7315974e-7,0.00003309723,0.0005747868,0.005959023,0.005625524],"study_design_scores_gemma":[0.012230464,0.0008339145,0.80819154,0.0013132857,0.000053781354,0.0000033196231,0.0065902644,0.00019565102,0.000106083105,0.00042665214,0.16988365,0.00017137894],"about_ca_topic_score_codex":0.0010304985,"about_ca_topic_score_gemma":0.0012451976,"teacher_disagreement_score":0.3551168,"about_ca_system_score_codex":0.00047072535,"about_ca_system_score_gemma":0.00031676446,"threshold_uncertainty_score":0.4100174},"labels":[],"label_agreement":null},{"id":"W3107142083","doi":"10.1016/j.ctarc.2020.100246","title":"The impact of synchronous malignancies on survival in patients with early stage curable non-small-cell lung cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; Sunnybrook Health Science Centre; Health Sciences Centre; Cancer Care Ontario; McMaster University; University Health Network; University of Toronto","funders":"Government of Ontario; Cancer Care Ontario","keywords":"Stage (stratigraphy); Lung cancer; Oncology; Medicine; Internal medicine; Cancer; Overall survival; Biology","score_opus":0.07345195613966087,"score_gpt":0.3851385666671447,"score_spread":0.3116866105274838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107142083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863706,0.007201628,0.0000020412037,0.002219977,0.000015419695,0.0010725885,0.00017151498,0.00000852533,0.0029376806],"genre_scores_gemma":[0.97560203,0.023135452,0.000044142962,0.000036420544,0.00002126241,0.0004026946,0.000044490942,0.000016927199,0.0006965863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989682,0.00014818281,0.00017726899,0.00018563369,0.0002227773,0.0002979785],"domain_scores_gemma":[0.99855953,0.00032287263,0.00006196808,0.0006673957,0.00023013467,0.00015812018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015893648,0.0001302398,0.00024462852,0.00007511355,0.000330635,0.00003219866,0.00025869516,0.000038476403,0.00007743406],"category_scores_gemma":[0.000018392737,0.00007122035,0.000057476285,0.00032463798,0.00030751267,0.000066819666,0.00010036547,0.00027371378,0.0000017474717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010684654,0.00039103068,0.98508286,0.00007877898,0.00024330529,0.000002077848,0.0029737984,0.00021327291,0.0002972479,0.00003431847,0.00031356225,0.009301299],"study_design_scores_gemma":[0.0052005574,0.0027114998,0.9875017,0.00019474029,0.000048743295,8.75748e-8,0.00047476043,0.0014354726,0.0005718613,0.0000022862725,0.0017611439,0.00009717844],"about_ca_topic_score_codex":0.014698123,"about_ca_topic_score_gemma":0.001932442,"teacher_disagreement_score":0.015933823,"about_ca_system_score_codex":0.0007406729,"about_ca_system_score_gemma":0.0010952915,"threshold_uncertainty_score":0.9918631},"labels":[],"label_agreement":null},{"id":"W3108071574","doi":"10.1016/j.ctarc.2020.100265","title":"Applicability of the PACIFIC trial results in patients not eligible for the PACIFIC trial: Canadian rapid consensus statement and recommendations.","year":2020,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; University of Ottawa; University of Toronto; Dalhousie University; University of British Columbia; McMaster University; Queen's University","funders":"","keywords":"Durvalumab; Medicine; Clinical trial; Family medicine; Intensive care medicine; Cancer; Internal medicine","score_opus":0.1934078137220699,"score_gpt":0.4404405117552331,"score_spread":0.2470326980331632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108071574","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43427175,0.0067397635,0.0000011059677,0.53911865,0.00016937507,0.016243117,0.0018798184,0.000015283309,0.0015611493],"genre_scores_gemma":[0.9737243,0.020856073,0.0001031693,0.0001150703,0.000038940332,0.004796606,0.00018501819,0.000011978947,0.00016884271],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99844843,0.00035886903,0.0004442473,0.00028914105,0.0001898228,0.000269471],"domain_scores_gemma":[0.9969186,0.0015066655,0.00010668789,0.0010200259,0.00026089983,0.00018712354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007681143,0.00012752238,0.00026691495,0.000083204286,0.00059766835,0.000040300583,0.00021343419,0.00005302275,0.00001788236],"category_scores_gemma":[0.00025339308,0.00006949576,0.000078524106,0.0003595312,0.00044219903,0.000025561081,0.00011649148,0.00018085896,0.0000012286192],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30517098,0.007352205,0.14457816,0.00037806798,0.0020772088,0.000001564905,0.020419983,0.000018865252,0.00008346556,0.002041917,0.0876971,0.4301805],"study_design_scores_gemma":[0.39255017,0.005909157,0.050348986,0.00021207177,0.00037170868,4.1023708e-7,0.004876579,0.0003256921,0.00076262956,0.00015873555,0.54430956,0.00017432355],"about_ca_topic_score_codex":0.024005733,"about_ca_topic_score_gemma":0.027749998,"teacher_disagreement_score":0.53945255,"about_ca_system_score_codex":0.0008185906,"about_ca_system_score_gemma":0.00083078886,"threshold_uncertainty_score":0.989991},"labels":[],"label_agreement":null},{"id":"W3109289476","doi":"10.1016/j.ctarc.2020.100244","title":"Cancer-related fatigue in head and neck cancer survivors: Energy and functional impacts","year":2020,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Cancer survivorship and care","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Alberta Health Services; University of Alberta","funders":"","keywords":"Head and neck cancer; Thematic analysis; Cancer; Exploratory research; Quality of life (healthcare); Cancer survivor; Medicine; Cancer-related fatigue; Exploratory analysis; Energy (signal processing); Clinical psychology; Psychology; Physical therapy; Gerontology; Internal medicine; Qualitative research; Nursing; Data science; Computer science","score_opus":0.19012865019185046,"score_gpt":0.42864773554791513,"score_spread":0.23851908535606467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109289476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76586646,0.17527495,0.000003924281,0.056693368,0.00007562483,0.00041555127,0.00012231413,0.00004510317,0.0015026733],"genre_scores_gemma":[0.76381844,0.23445883,0.000029478182,0.0003039807,0.00008033929,0.00067956257,0.00006480782,0.000017880317,0.0005467048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867773,0.00020730328,0.00021487146,0.00033842854,0.00023173596,0.0003299048],"domain_scores_gemma":[0.99868214,0.00024333832,0.000041918913,0.0004280541,0.0001920538,0.00041249764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015779345,0.00017212419,0.00029607615,0.00015904052,0.00033453963,0.00005660909,0.0001097939,0.0001044948,0.00016339697],"category_scores_gemma":[0.00003230936,0.00013880974,0.000038005397,0.0005843329,0.00036300393,0.00011374362,0.000197919,0.00028752853,9.568676e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006133427,0.00043351922,0.8385096,0.00025594837,0.00058908697,0.00001587319,0.017025154,0.000028517201,0.0015707952,0.0022210875,0.0018816656,0.13685538],"study_design_scores_gemma":[0.009729235,0.0014609048,0.70712686,0.0011874794,0.00029999888,0.000020496102,0.0040694694,0.0048990822,0.0009932483,0.00047025,0.2692093,0.0005337017],"about_ca_topic_score_codex":0.1426847,"about_ca_topic_score_gemma":0.31560668,"teacher_disagreement_score":0.2673276,"about_ca_system_score_codex":0.00044138884,"about_ca_system_score_gemma":0.000573133,"threshold_uncertainty_score":0.86302423},"labels":[],"label_agreement":null},{"id":"W3109625109","doi":"10.1016/j.ctarc.2020.100249","title":"Association between continuous decrease of plasma VEGF-A levels and the efficacy of chemotherapy in combination with anti-programmed cell death 1 antibody in non-small cell lung cancer patients","year":2020,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Company; Eli Lilly Japan; Chugai Pharmaceutical; Pfizer Japan; MSD K.K.; Eisai; Ono Pharmaceutical; Bristol-Myers Squibb Canada; Novartis; Otsuka Pharmaceutical; Astellas Pharma; Kyowa Hakko Kirin; Taiho Pharmaceutical; AstraZeneca","keywords":"Lung cancer; Vascular endothelial growth factor; Medicine; Chemotherapy; Internal medicine; Oncology; Antibody; Cancer; VEGF receptors; Gastroenterology; Immunology","score_opus":0.039500060705252166,"score_gpt":0.3540200462152083,"score_spread":0.3145199855099561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109625109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917003,0.0060743913,0.000017119242,0.0011837619,0.000006189628,0.00081200176,0.00007323025,0.0000018633884,0.00013115477],"genre_scores_gemma":[0.9779575,0.021453615,0.00014584427,0.000024868574,0.000017656968,0.00021290596,0.00012254136,0.000011960582,0.000053105625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911344,0.00021333102,0.00020509498,0.00017707492,0.0001250082,0.00016607456],"domain_scores_gemma":[0.9991352,0.00019435119,0.00014192503,0.00025873687,0.00020570813,0.00006407271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002631759,0.000098524855,0.00022362423,0.000054274256,0.00008570137,0.000014776255,0.00019274339,0.000077818666,0.0000036658764],"category_scores_gemma":[0.000035866284,0.00006795253,0.000036495552,0.00021552593,0.00017762388,0.0000061514984,0.000095895695,0.00008978349,7.6972576e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002531078,0.00042517067,0.9810211,0.000053080355,0.0001103856,1.3426101e-7,0.001154422,0.000015047747,0.012232168,0.000012046429,0.000024223204,0.00469909],"study_design_scores_gemma":[0.014795975,0.0006034663,0.9180609,0.00010071616,0.00008615329,5.157419e-8,0.00026739214,0.0006853572,0.06469216,0.000006899219,0.00059284695,0.00010811253],"about_ca_topic_score_codex":0.00198598,"about_ca_topic_score_gemma":0.0006188177,"teacher_disagreement_score":0.06296025,"about_ca_system_score_codex":0.00008812581,"about_ca_system_score_gemma":0.00017838675,"threshold_uncertainty_score":0.3002221},"labels":[],"label_agreement":null},{"id":"W3111935365","doi":"10.1016/j.ctarc.2020.100287","title":"Salvage surgery for locally recurrent anal cancer after intensity modulated radiation therapy with concurrent chemotherapy","year":2020,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre","funders":"","keywords":"Medicine; Surgery; Salvage therapy; Salvage surgery; Radiation therapy; Anal cancer; Cancer; Chemotherapy; Internal medicine","score_opus":0.17769726650268317,"score_gpt":0.4121883678049259,"score_spread":0.23449110130224274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111935365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89835304,0.04576924,0.000074312244,0.054373085,0.000040107294,0.0011944954,0.00009653522,0.000036597325,0.000062609775],"genre_scores_gemma":[0.92075825,0.076818615,0.00007601722,0.00056241866,0.00013655033,0.0013584285,0.00015042385,0.000017398988,0.000121870624],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990902,0.00009101355,0.0001581248,0.00024249747,0.00018171944,0.00023647702],"domain_scores_gemma":[0.9987465,0.00020820765,0.000044404467,0.00032968682,0.0004464726,0.00022471153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014497133,0.00013597775,0.00028162097,0.000085722546,0.00023903216,0.0000333855,0.000100496756,0.000046902707,0.00007978421],"category_scores_gemma":[0.000022745571,0.00008817149,0.00009234633,0.00033437708,0.00026865132,0.00005375181,0.000046530877,0.000184075,0.0000017839998],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006327433,0.0006429782,0.16894138,0.00009147566,0.00059273356,0.0000067598176,0.003078069,0.0000054558654,0.0017615573,0.00004002983,0.0022784607,0.8162337],"study_design_scores_gemma":[0.010655283,0.006408246,0.7771351,0.0005834654,0.00025628376,0.000010335116,0.00064340176,0.017896084,0.007098911,0.00010648672,0.1787326,0.00047381638],"about_ca_topic_score_codex":0.0004962275,"about_ca_topic_score_gemma":0.00049250375,"teacher_disagreement_score":0.81575984,"about_ca_system_score_codex":0.00028376942,"about_ca_system_score_gemma":0.0004292755,"threshold_uncertainty_score":0.3595529},"labels":[],"label_agreement":null},{"id":"W3117695288","doi":"10.1016/j.ctarc.2020.100294","title":"Chemotherapy for Non-Small Cell Lung Cancer in the Intensive Care Unit","year":2020,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Pemetrexed; Medicine; Chemotherapy; Intensive care unit; Lung cancer; Malignancy; Cisplatin; Adenocarcinoma; Intensive care; Oncology; Intensive care medicine; Internal medicine; Cancer","score_opus":0.14625037072315633,"score_gpt":0.45689690989330056,"score_spread":0.31064653917014423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3117695288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5599383,0.12721679,0.000016778686,0.3031101,0.00004999083,0.005536852,0.00027370898,0.000028836139,0.003828618],"genre_scores_gemma":[0.8848304,0.10594853,0.00020885235,0.0020423003,0.000101816164,0.0065467698,0.00008856791,0.000020073807,0.000212702],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990958,0.00010834322,0.00014354734,0.00024119238,0.00014080941,0.00027030133],"domain_scores_gemma":[0.9982554,0.00042247778,0.00003376391,0.00066937314,0.00048989203,0.00012913437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001000585,0.00013509627,0.0002211594,0.00007092674,0.00034049916,0.000042911764,0.00028642442,0.000052462252,0.000038288348],"category_scores_gemma":[0.000025208155,0.00008087508,0.000078840225,0.00033773488,0.00017294874,0.00003232892,0.00008031755,0.00021125544,0.0000020907214],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006805051,0.0009330658,0.7558027,0.00083409814,0.00073783833,0.000015423439,0.14862877,0.000029900008,0.0010819507,0.00048812313,0.010642033,0.0801256],"study_design_scores_gemma":[0.045669507,0.006364859,0.3120733,0.0021164406,0.0016742412,0.000008256067,0.16229326,0.008043259,0.020230459,0.00015692877,0.4406153,0.0007541929],"about_ca_topic_score_codex":0.002175193,"about_ca_topic_score_gemma":0.0022091663,"teacher_disagreement_score":0.44372937,"about_ca_system_score_codex":0.00044365934,"about_ca_system_score_gemma":0.000482499,"threshold_uncertainty_score":0.329799},"labels":[],"label_agreement":null},{"id":"W3126798229","doi":"10.1016/j.ctarc.2021.100330","title":"A single institution study evaluating outcomes of PD-L1 high KRAS-mutant advanced non-small cell lung cancer (NSCLC) patients treated with first line immune checkpoint inhibitors","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"KRAS; Medicine; Internal medicine; Oncology; Lung cancer; Cancer; Adverse effect; Colorectal cancer","score_opus":0.0786849360391814,"score_gpt":0.40058061211302104,"score_spread":0.3218956760738396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126798229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752997,0.020092642,0.00000721588,0.0017239521,0.00007252848,0.0023077908,0.00009656409,0.000030140749,0.00036943663],"genre_scores_gemma":[0.97118044,0.025982117,0.0005056231,0.000021684511,0.000031479914,0.0014595935,0.00019189833,0.000032725853,0.0005944161],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979891,0.0002574115,0.0005589944,0.00038688508,0.0004527377,0.0003548757],"domain_scores_gemma":[0.99710625,0.00028709366,0.00021799284,0.0011809609,0.0010775649,0.00013010396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003742371,0.00025698793,0.0005191158,0.00017933497,0.00065374054,0.00004365161,0.00021334377,0.00007984507,0.00007615206],"category_scores_gemma":[0.00007457829,0.00017771265,0.00012126596,0.00085076224,0.00037356664,0.000114029426,0.00020876894,0.00025976685,0.0000010729399],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025159214,0.008546894,0.8638816,0.00024551677,0.0014780875,0.000012523981,0.0050791637,0.000081024016,0.076166056,0.0000056314952,0.000025744139,0.04196182],"study_design_scores_gemma":[0.030419119,0.007867158,0.7965129,0.0019852163,0.0009198526,0.000003916833,0.003399466,0.0005774524,0.157068,0.0000053295926,0.00089271757,0.00034888863],"about_ca_topic_score_codex":0.011492285,"about_ca_topic_score_gemma":0.010945633,"teacher_disagreement_score":0.080901936,"about_ca_system_score_codex":0.0012076104,"about_ca_system_score_gemma":0.001125526,"threshold_uncertainty_score":0.99509025},"labels":[],"label_agreement":null},{"id":"W3137491601","doi":"10.1016/j.ctarc.2021.100353","title":"Discordance in PD-L1 scores on repeat testing of non-small cell lung carcinomas","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Oncology; Pleural effusion; Carcinoma; Biopsy; Retrospective cohort study; Malignant pleural effusion; Pathology","score_opus":0.14059017514654282,"score_gpt":0.4125888941020173,"score_spread":0.2719987189554745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137491601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92983806,0.0591078,0.0000029486696,0.002758024,0.000028274097,0.00046415348,0.000025386555,0.000009674123,0.0077656563],"genre_scores_gemma":[0.9520269,0.04441165,0.0011856329,0.000046164398,0.000029369072,0.0002846927,0.000037478487,0.000013742972,0.0019643519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989857,0.00016664356,0.0002258345,0.00022587643,0.0001619011,0.00023402082],"domain_scores_gemma":[0.9980672,0.0005261295,0.000050645303,0.0010561374,0.00022474637,0.00007516807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026005058,0.000105286905,0.00022106357,0.00012970313,0.00020886333,0.000021205995,0.00017347855,0.000044040517,0.000027401074],"category_scores_gemma":[0.00006775718,0.000081308266,0.00005838347,0.00062556175,0.0003098985,0.000035822137,0.00013620158,0.000223074,0.0000014172592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007708563,0.0012563489,0.8247556,0.00027393107,0.00015264058,0.000048243928,0.0023253676,0.0000123925,0.115916625,0.00012046565,0.000502275,0.053865265],"study_design_scores_gemma":[0.0060653575,0.0011857282,0.8746487,0.0021038074,0.00009537596,0.000020609581,0.0019345795,0.0013614233,0.10584072,0.000077592325,0.0064719836,0.00019412371],"about_ca_topic_score_codex":0.0037116045,"about_ca_topic_score_gemma":0.0025354424,"teacher_disagreement_score":0.05367114,"about_ca_system_score_codex":0.00039329563,"about_ca_system_score_gemma":0.0006338378,"threshold_uncertainty_score":0.56108606},"labels":[],"label_agreement":null},{"id":"W3146059679","doi":"10.1016/j.ctarc.2021.100363","title":"Endometrial Stem/Progenitor cell (ES/PC) Marker Expression Profile in Adenosarcoma and Endometrial Stromal Sarcoma","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Toronto General Hospital; University of Toronto; McGill University Health Centre; St. Michael's Hospital","funders":"","keywords":"Stromal cell; Biology; Stem cell; Progenitor cell; Cancer research; Carcinogenesis; Endometrial stromal sarcoma; Cell biology; Cancer; Genetics","score_opus":0.12408277140251638,"score_gpt":0.4087666330982965,"score_spread":0.2846838616957801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3146059679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95812154,0.03531869,0.0000020261266,0.0026085088,0.0000912874,0.0012350542,0.00014405575,0.000026767153,0.0024520473],"genre_scores_gemma":[0.9688011,0.023637487,0.00287506,0.0000126460345,0.00017122539,0.0010595028,0.0001949939,0.000027915532,0.003220085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979626,0.0005410039,0.00030855447,0.00040850652,0.00035109508,0.00042822515],"domain_scores_gemma":[0.9976433,0.00078610366,0.000057778412,0.0010042065,0.00022766937,0.00028094184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031106724,0.00020159551,0.00040347836,0.0004800338,0.00039943037,0.00010154787,0.00018474781,0.000109276814,0.00023665308],"category_scores_gemma":[0.00010179607,0.00015252765,0.00008493376,0.00082885305,0.00027257673,0.00012633164,0.00056558877,0.00031525732,0.000012783816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003350737,0.0069301324,0.695406,0.00026498138,0.00070167554,0.0005535321,0.0016061177,2.6492594e-7,0.16361986,0.00049765885,0.0012433114,0.12582573],"study_design_scores_gemma":[0.11255401,0.0069033667,0.39268395,0.0011345504,0.000686092,0.00033380213,0.0040698745,0.0004436094,0.34606454,0.00025383147,0.13400131,0.00087105564],"about_ca_topic_score_codex":0.00046608245,"about_ca_topic_score_gemma":0.00020760302,"teacher_disagreement_score":0.30272204,"about_ca_system_score_codex":0.00036983393,"about_ca_system_score_gemma":0.00041756014,"threshold_uncertainty_score":0.6219897},"labels":[],"label_agreement":null},{"id":"W3155354072","doi":"10.1016/j.ctarc.2021.100376","title":"Proteomic signatures of radioresistance: Alteration of inflammation, angiogenesis and metabolism-related factors in radioresistant oesophageal adenocarcinoma","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Science Foundation Ireland","keywords":"Radioresistance; Cancer research; Biology; Angiogenesis; Proteomics; Radiation therapy; Bioinformatics; Medicine; Internal medicine; Gene; Genetics","score_opus":0.05448878591090385,"score_gpt":0.374296516555609,"score_spread":0.3198077306447052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155354072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7588549,0.23863752,0.0000024428355,0.0014732277,0.000011317711,0.0008077901,0.000087108405,0.000008317118,0.00011736022],"genre_scores_gemma":[0.94745463,0.05102536,0.00056480267,0.0000038964963,0.000019562913,0.000381546,0.00020810738,0.00001578153,0.00032628785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824446,0.0004486867,0.0004151979,0.0002737307,0.00035451597,0.00026343387],"domain_scores_gemma":[0.9982212,0.00028517688,0.000102668826,0.0007143963,0.0005084334,0.00016812098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033426002,0.00015384908,0.00043496874,0.00038737457,0.00019548477,0.000024423256,0.00013711014,0.000094667324,0.00005079104],"category_scores_gemma":[0.000118353906,0.000117517695,0.00008250352,0.0007264801,0.0005452884,0.0001119675,0.00011850255,0.00020137591,5.3463106e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007128825,0.00095070014,0.8701896,0.00053204887,0.0010271173,0.00007813873,0.0056400513,0.00003278581,0.10370545,0.005925058,0.000075639575,0.01113054],"study_design_scores_gemma":[0.0032085509,0.00033083156,0.81944,0.0002256216,0.00014748426,0.000007274044,0.0004808124,0.00020000739,0.17528592,0.00043885843,0.00015527185,0.000079356614],"about_ca_topic_score_codex":0.0009863008,"about_ca_topic_score_gemma":0.00065183145,"teacher_disagreement_score":0.18859975,"about_ca_system_score_codex":0.00033245806,"about_ca_system_score_gemma":0.00074804,"threshold_uncertainty_score":0.47922325},"labels":[],"label_agreement":null},{"id":"W3156170207","doi":"10.1016/j.ctarc.2021.100378","title":"RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Eli Lilly and Company","keywords":"Erlotinib; Ramucirumab; Internal medicine; Medicine; Placebo; Population; Oncology; Lung cancer; Subgroup analysis; Gastroenterology; Cancer; Epidermal growth factor receptor; Pathology; Confidence interval","score_opus":0.060560401384030245,"score_gpt":0.4003621795605682,"score_spread":0.33980177817653795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156170207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97269446,0.015581828,0.000036937567,0.004350194,0.000087882865,0.0034676527,0.0011505957,0.00008213746,0.0025483344],"genre_scores_gemma":[0.9350438,0.04428303,0.0013949351,0.00011406662,0.000032076612,0.002954257,0.01055301,0.00009225395,0.0055325506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967067,0.0006772063,0.00053984363,0.00073611474,0.000554487,0.00078561687],"domain_scores_gemma":[0.99535906,0.0008606362,0.00018416416,0.0017042598,0.0014484779,0.00044338722],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029662525,0.00043644855,0.00080174033,0.001029586,0.0007776949,0.00016689088,0.00037144235,0.00010081933,0.0002476114],"category_scores_gemma":[0.00006837204,0.00032741396,0.00015120277,0.004814568,0.00041216073,0.0001707642,0.0002675245,0.0005507273,0.000016176802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011397669,0.005817514,0.9037652,0.0004904563,0.021052655,0.00042447855,0.02137161,0.02555294,0.00006184813,0.00017821169,0.002122553,0.0077648577],"study_design_scores_gemma":[0.2801751,0.006768083,0.52115095,0.0021124624,0.040831592,0.000024584451,0.019646911,0.08563576,0.0015312575,0.000038568294,0.03996219,0.0021225654],"about_ca_topic_score_codex":0.01952549,"about_ca_topic_score_gemma":0.029833019,"teacher_disagreement_score":0.38261428,"about_ca_system_score_codex":0.0030353605,"about_ca_system_score_gemma":0.0027582722,"threshold_uncertainty_score":0.9999178},"labels":[],"label_agreement":null},{"id":"W3164270701","doi":"10.1016/j.ctarc.2021.100401","title":"Developing a clinical-pathologic model to predict genomic risk of recurrence in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative, node negative breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of Alberta; University of Calgary","funders":"","keywords":"Internal medicine; Medicine; Breast cancer; Oncology; Odds ratio; Logistic regression; Confidence interval; Hormone receptor; Cancer","score_opus":0.08719592673020116,"score_gpt":0.3966071531470477,"score_spread":0.30941122641684654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164270701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98838085,0.00411851,0.00009916735,0.0026118883,0.00003078016,0.0007988209,0.003793798,0.000010093281,0.00015607725],"genre_scores_gemma":[0.9429381,0.047598023,0.0078722965,0.00006365714,0.00004414751,0.0009821,0.00037609212,0.000026612855,0.000098978024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758345,0.00080340425,0.0004051325,0.0005982467,0.00021228763,0.00039747232],"domain_scores_gemma":[0.997527,0.00027018756,0.00018208343,0.00077784795,0.0010896977,0.00015317665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002509707,0.00025790904,0.00039937193,0.00011978179,0.0004961574,0.000026844951,0.0003712668,0.000119380675,0.000019160301],"category_scores_gemma":[0.00018028152,0.00020107915,0.00007508872,0.00045309868,0.00065197865,0.000022271195,0.00064109545,0.0002742076,0.00000236914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078325626,0.00083515706,0.9807216,0.000018938228,0.00061423617,0.0000011237952,0.0012353985,0.00009980898,0.003120943,0.00008550831,0.0002846816,0.012199341],"study_design_scores_gemma":[0.0031993059,0.0005368647,0.9900414,0.00018201978,0.00006348379,8.8153945e-7,0.00029924817,0.000045744513,0.0051754154,0.000111861096,0.00011852038,0.00022527171],"about_ca_topic_score_codex":0.0023853655,"about_ca_topic_score_gemma":0.003098816,"teacher_disagreement_score":0.04544277,"about_ca_system_score_codex":0.0005298468,"about_ca_system_score_gemma":0.0007290038,"threshold_uncertainty_score":0.819977},"labels":[],"label_agreement":null},{"id":"W3164647557","doi":"10.1016/j.ctarc.2021.100403","title":"Predictive factors associated with radiation dermatitis in breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Erythema; Breast cancer; Univariate analysis; Radiation therapy; Edema; Gastroenterology; Cancer; Surgery; Multivariate analysis","score_opus":0.07153526143740871,"score_gpt":0.404114585665896,"score_spread":0.33257932422848724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164647557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94700956,0.01549873,0.000005243336,0.035207048,0.000025526464,0.0006105387,0.000308838,0.00003679007,0.0012977422],"genre_scores_gemma":[0.96796453,0.03020904,0.000048091988,0.00008312313,0.000028434813,0.00062773336,0.0003961195,0.000014730432,0.0006281999],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888295,0.00036566175,0.00012968258,0.0001751122,0.00023324415,0.00021337789],"domain_scores_gemma":[0.99835646,0.00053834793,0.00004475613,0.0005005604,0.00043280586,0.00012704609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013510881,0.00009832697,0.00018468023,0.00016679536,0.00026023205,0.000035329525,0.00009190476,0.00007061777,0.00010884601],"category_scores_gemma":[0.00010488344,0.00007296291,0.00002752266,0.00062088406,0.00020233734,0.000133429,0.000055270353,0.00024520003,0.0000017449751],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032153195,0.00044819296,0.98328876,0.000019390802,0.00029994737,0.000009515172,0.002208518,0.000044947104,0.00040633703,0.0001256141,0.0007253632,0.01239125],"study_design_scores_gemma":[0.0022212442,0.00017075846,0.9922845,0.0002826598,0.00007519895,0.000006523752,0.0006874215,0.0010051564,0.0008737885,0.00003033613,0.0022927679,0.00006966304],"about_ca_topic_score_codex":0.0014557049,"about_ca_topic_score_gemma":0.005691955,"teacher_disagreement_score":0.035123926,"about_ca_system_score_codex":0.0011303723,"about_ca_system_score_gemma":0.00078067655,"threshold_uncertainty_score":0.31762442},"labels":[],"label_agreement":null},{"id":"W3169117957","doi":"10.1016/j.ctarc.2021.100414","title":"Practical management and assessment of primary plasma cell leukemia in the novel agent era","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment and Research Communications","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Cancer Institute","keywords":"Plasma cell leukemia; Malignancy; Medicine; Multiple myeloma; Leukemia; Clinical trial; Oncology; Internal medicine","score_opus":0.40737040633907273,"score_gpt":0.5537650122771408,"score_spread":0.14639460593806808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169117957","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002715572,0.9785258,0.000006521229,0.0014599224,0.000017372824,0.0031696171,0.00012570423,0.0000074218715,0.016416082],"genre_scores_gemma":[0.00094616215,0.98355335,0.009688688,0.000018325833,0.000028288985,0.0035572604,0.00064379355,0.00002806285,0.0015360386],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99710226,0.0009665694,0.000461984,0.00041822705,0.0006357256,0.0004152186],"domain_scores_gemma":[0.9960623,0.0017505216,0.00012466157,0.0016941706,0.00016834601,0.00020002833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086478196,0.00028296642,0.0010299807,0.00038820994,0.00031491052,0.00008020649,0.00036372748,0.00014511368,0.000036755926],"category_scores_gemma":[0.000044799548,0.00016292803,0.00017643232,0.00060574606,0.00051116076,0.0000570641,0.0007312514,0.0009770871,0.0000036064469],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030539963,0.0022234372,0.00074364984,0.008081502,0.0011768899,0.00016643935,0.0003198403,3.0439455e-7,0.0000033248248,0.0016707338,0.0007123739,0.984871],"study_design_scores_gemma":[0.002842023,0.00042550295,0.0036120156,0.005862879,0.0010352248,0.00007873578,0.0005137069,0.00020494433,0.0000036047618,0.000009585639,0.98527795,0.00013380045],"about_ca_topic_score_codex":0.00094621745,"about_ca_topic_score_gemma":0.00035380773,"teacher_disagreement_score":0.98473716,"about_ca_system_score_codex":0.002898639,"about_ca_system_score_gemma":0.0035830685,"threshold_uncertainty_score":0.75798404},"labels":[],"label_agreement":null},{"id":"W3170157402","doi":"10.1016/j.ctarc.2021.100421","title":"A phase I/II study of pembrolizumab in combination with nab-paclitaxel in patients with unresectable stage III or stage IV non small-cell lung carcinoma (NSCLC)","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Centre Hospitalier de l’Université de Montréal","funders":"Merck","keywords":"Stage (stratigraphy); Pembrolizumab; Medicine; Oncology; Internal medicine; Paclitaxel; Nab-paclitaxel; Carcinoma; Chemotherapy; Cancer; Immunotherapy; Biology","score_opus":0.07057552295191545,"score_gpt":0.3883166627883285,"score_spread":0.31774113983641306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170157402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908946,0.0051108887,0.0000034023485,0.0005165147,0.000013371562,0.002482564,0.00007183624,0.000009118071,0.00089769147],"genre_scores_gemma":[0.9906484,0.0035320641,0.00011488342,0.000017023418,0.000005882765,0.00087923004,0.00016737463,0.000023336044,0.004611809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983419,0.0003413373,0.00031156436,0.00030509543,0.00037968333,0.00032042913],"domain_scores_gemma":[0.9981173,0.00019248755,0.00009527556,0.0010453432,0.00045442514,0.00009511986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003455606,0.00016724806,0.000356165,0.00031493334,0.00029809214,0.000033223387,0.00021301236,0.000056191104,0.00009758812],"category_scores_gemma":[0.000016744012,0.00011060743,0.000028750788,0.0011497263,0.00022322909,0.00011472782,0.0001733967,0.0002828112,2.724889e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031941414,0.04516632,0.8955336,0.00026345075,0.00038155116,0.00006531223,0.015850523,0.000014341009,0.0015908389,0.000029279496,0.00008349022,0.009079833],"study_design_scores_gemma":[0.27494848,0.045470316,0.6475347,0.00086818426,0.00016806484,0.0000027656681,0.025142385,0.0010969543,0.0027955018,0.0000035168023,0.0016939281,0.0002751477],"about_ca_topic_score_codex":0.013792756,"about_ca_topic_score_gemma":0.043701854,"teacher_disagreement_score":0.2479989,"about_ca_system_score_codex":0.0008333504,"about_ca_system_score_gemma":0.0011759439,"threshold_uncertainty_score":0.9927745},"labels":[],"label_agreement":null},{"id":"W3171042793","doi":"10.1016/j.ctarc.2021.100405","title":"Safety, pharmacokinetics, and efficacy of budigalimab with rovalpituzumab tesirine in patients with small cell lung cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cilag; Takeda Oncology; Chugai Pharmaceutical; Genentech; Aptitude Health; Sierra Oncology; Sociedad Española de Oncología Médica; PharmaMar; European Society for Medical Oncology; Oryzon Genomics; Astellas Pharma; Eisai; MacroGenics; Mersana Therapeutics; Agios Pharmaceuticals; BeiGene; Clovis Oncology; Loxo Oncology; Astex Pharmaceuticals; Les Laboratories Pierre Fabre; Pfizer; Incyte; Taiho Pharmaceutical; Regeneron Pharmaceuticals; Array BioPharma; Daiichi Sankyo Europe; Servier; Gilead Sciences; Glenmark Pharmaceuticals; AbbVie; Exelixis; Sanofi; Bristol-Myers Squibb; Ignyta; Eli Lilly and Company; EUSA Pharma; AstraZeneca; Argenx; American Society of Clinical Oncology; GlaxoSmithKline; Amgen; LAM Therapeutics; Celgene","keywords":"Tolerability; Medicine; Internal medicine; Adverse effect; Lung cancer; Oncology; Pharmacokinetics; Pleural effusion; Clinical trial; Gastroenterology","score_opus":0.06452351404831635,"score_gpt":0.41405822557187255,"score_spread":0.3495347115235562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171042793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.924476,0.06449292,0.000004274679,0.0073552695,0.0000119451415,0.0013530308,0.00010945433,0.0000146246075,0.002182429],"genre_scores_gemma":[0.8775381,0.11986033,0.00085516623,0.000027583494,0.000022705566,0.00048323907,0.00007706212,0.000024298977,0.0011115527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985398,0.0001926417,0.00020973069,0.00031284598,0.00037851525,0.0003664435],"domain_scores_gemma":[0.99772656,0.0004020361,0.000055263215,0.0007897028,0.0008565847,0.00016983741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018564968,0.00016303532,0.00035672027,0.00018910549,0.00025296616,0.00002597848,0.00016727098,0.000036514335,0.000053535605],"category_scores_gemma":[0.000044825665,0.00010634024,0.000025360485,0.00061680475,0.0007104309,0.000056624154,0.00037431763,0.00031498767,4.8501306e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015569038,0.001653207,0.9725138,0.00039036904,0.00060831587,0.000014968862,0.0016126486,0.000024899342,0.00048285187,0.0000599922,0.00020961878,0.020872425],"study_design_scores_gemma":[0.028196884,0.001658206,0.95357656,0.0010965664,0.00039959874,0.0000035426306,0.00052695157,0.00026007945,0.005527779,0.000010759734,0.008552388,0.00019066875],"about_ca_topic_score_codex":0.0024058614,"about_ca_topic_score_gemma":0.0033972673,"teacher_disagreement_score":0.05536741,"about_ca_system_score_codex":0.00067122444,"about_ca_system_score_gemma":0.00096595276,"threshold_uncertainty_score":0.4336429},"labels":[],"label_agreement":null},{"id":"W3211214132","doi":"10.1016/j.ctarc.2021.100484","title":"Integrating NGS-derived mutational profiling in the diagnosis of multiple lung adenocarcinomas","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Université de Montréal; McGill University Health Centre","funders":"McGill University Health Centre","keywords":"KRAS; Adenocarcinoma; Lung cancer; DNA sequencing; Medicine; Mutation rate; Lung; Metastasis; Mutation; Cancer; Oncology; Computational biology; Internal medicine; Gene; Biology; Genetics; Colorectal cancer","score_opus":0.1571328090392377,"score_gpt":0.4517968917299002,"score_spread":0.29466408269066247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211214132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92337716,0.053270996,0.000005948038,0.020639235,0.000022263452,0.00086007995,0.00005302377,0.000009713669,0.0017616084],"genre_scores_gemma":[0.965306,0.029256983,0.0019081011,0.000069687456,0.000034272736,0.003133829,0.00017578999,0.0000099493445,0.000105383006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880064,0.00033868002,0.00022201888,0.00019781818,0.0002461259,0.00019469435],"domain_scores_gemma":[0.9973292,0.0015309822,0.000047011057,0.00069337856,0.00033838552,0.00006104065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000307327,0.00009836624,0.00020044124,0.000110326146,0.00029117457,0.000033225453,0.00016429176,0.00004148748,0.000048952446],"category_scores_gemma":[0.0001896287,0.00006122751,0.00006771545,0.00045526918,0.00025252745,0.000055199293,0.000114598515,0.0002110647,0.0000014481227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037805625,0.0010880413,0.9795446,0.000084355925,0.00020083915,0.000025193718,0.00478598,0.000008032135,0.0008803767,0.0024462827,0.00018048965,0.010718016],"study_design_scores_gemma":[0.0058401097,0.0005511474,0.91970766,0.0011466568,0.0003220022,0.000040894098,0.015322134,0.0027048928,0.050092477,0.000495661,0.0036158205,0.00016053946],"about_ca_topic_score_codex":0.0016974439,"about_ca_topic_score_gemma":0.0028559987,"teacher_disagreement_score":0.059836924,"about_ca_system_score_codex":0.0004937342,"about_ca_system_score_gemma":0.0005367468,"threshold_uncertainty_score":0.25660387},"labels":[],"label_agreement":null},{"id":"W3214742056","doi":"10.1016/j.ctarc.2021.100496","title":"Consolidative durvalumab outcomes in stage III non-small cell lung cancer in a multi-centre study","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; Queen's University","funders":"","keywords":"Durvalumab; Medicine; Pneumonitis; Internal medicine; Discontinuation; Lung cancer; Stage (stratigraphy); Clinical endpoint; Hazard ratio; Cancer; Oncology; Radiation therapy; Retrospective cohort study; Gastroenterology; Lung; Immunotherapy; Nivolumab; Clinical trial; Confidence interval","score_opus":0.13774220181707245,"score_gpt":0.464566545389948,"score_spread":0.3268243435728756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214742056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9472225,0.044232085,0.000002697324,0.005410674,0.000046141737,0.001982868,0.00011984051,0.0000141233395,0.00096906995],"genre_scores_gemma":[0.91335505,0.07403894,0.00019891451,0.00007180632,0.000011612967,0.001341319,0.000044397788,0.000018881281,0.010919093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824756,0.00049908605,0.00032185973,0.00034264446,0.00020720108,0.0003816663],"domain_scores_gemma":[0.9982302,0.00036621772,0.000054906082,0.0009841488,0.0002504866,0.00011402052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041497068,0.0001739627,0.00040236325,0.00021486799,0.00024694094,0.000047091857,0.00022136098,0.0000701808,0.00033363892],"category_scores_gemma":[0.000032403004,0.00013622291,0.00007162202,0.0006453337,0.00025419466,0.00006618658,0.0002351672,0.0003784321,0.0000030104088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004203383,0.005110944,0.96668005,0.000061459665,0.00037977388,0.0000699079,0.018006673,0.000008730033,0.0022569234,0.000011580977,0.000120272336,0.006873317],"study_design_scores_gemma":[0.036886398,0.0003698554,0.9086703,0.0005321451,0.00013652022,0.0000024324572,0.043235175,0.0017498124,0.0027322767,0.0000043091422,0.005428518,0.00025223245],"about_ca_topic_score_codex":0.026040306,"about_ca_topic_score_gemma":0.13379285,"teacher_disagreement_score":0.10775255,"about_ca_system_score_codex":0.0012544383,"about_ca_system_score_gemma":0.0012467541,"threshold_uncertainty_score":0.9804454},"labels":[],"label_agreement":null},{"id":"W3214859407","doi":"10.1016/j.ctarc.2021.100494","title":"Aging-associated immune system changes in multiple myeloma: The dark side of the moon.","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment and Research Communications","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Immunosenescence; Immunosurveillance; Immune system; Disease; Immunology; Medicine; Immunotherapy; Bone marrow; Senescence; Internal medicine","score_opus":0.24505326140434658,"score_gpt":0.465090804440809,"score_spread":0.22003754303646245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214859407","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007970477,0.9909037,1.3493134e-7,0.0030914543,0.000058950918,0.0034797161,0.00031897952,0.000022708491,0.0013273156],"genre_scores_gemma":[0.05388077,0.93937343,0.000031965694,0.0000063427356,0.000045232413,0.003981098,0.00041510502,0.00004578182,0.0022202597],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954359,0.0024828417,0.0005420502,0.0003796075,0.0005884328,0.00057115586],"domain_scores_gemma":[0.99354357,0.0025812788,0.0002484538,0.003031858,0.00043899755,0.000155839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010121079,0.00033660638,0.0013811627,0.00032400244,0.0008611291,0.00006297942,0.0009628355,0.00020887192,0.000022355558],"category_scores_gemma":[0.00053655426,0.00015994058,0.00038777126,0.0014899268,0.0008732068,0.00003470176,0.0010435195,0.00092773564,0.000008815675],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003213251,0.0011055932,0.00476921,0.004769083,0.002459462,0.00004078591,0.0008089981,6.0997263e-7,0.00002034523,0.00037349365,0.00021675619,0.98540354],"study_design_scores_gemma":[0.004393663,0.0003851006,0.011715174,0.06141781,0.0016876329,0.000063673986,0.0018397892,0.00017335948,0.0001813107,0.000015342182,0.9178211,0.00030603752],"about_ca_topic_score_codex":0.0052956413,"about_ca_topic_score_gemma":0.010851009,"teacher_disagreement_score":0.98509747,"about_ca_system_score_codex":0.0020236606,"about_ca_system_score_gemma":0.0016713145,"threshold_uncertainty_score":0.80054605},"labels":[],"label_agreement":null},{"id":"W3216326311","doi":"10.1016/j.ctarc.2021.100495","title":"Rural vs urban inequalities in stage at diagnosis for lung cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary; University of Saskatchewan","funders":"Saskatchewan Health Research Foundation","keywords":"Relative risk; Medicine; Lung cancer; Incidence (geometry); Relative survival; Stage (stratigraphy); Confidence interval; Cancer registry; Rural area; Cancer; Internal medicine; Demography; Cohort; Pathology","score_opus":0.36605763880834563,"score_gpt":0.526954167958974,"score_spread":0.16089652915062835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216326311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8042423,0.16441388,0.000007352093,0.028228339,0.000049813403,0.000830687,0.0003253925,0.000021977357,0.0018802237],"genre_scores_gemma":[0.83430237,0.14680621,0.00042772305,0.00023801073,0.00009035065,0.005398542,0.0001845935,0.000014514173,0.012537709],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988583,0.0001705926,0.00019810573,0.0001967375,0.00021785349,0.0003584337],"domain_scores_gemma":[0.99819684,0.0005573409,0.000033088585,0.0007050269,0.0003636948,0.0001439998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028763854,0.000109269626,0.00024418178,0.000114554015,0.0004584581,0.000045708766,0.0001667077,0.00006010478,0.00028215212],"category_scores_gemma":[0.00011845558,0.000089550456,0.00006840232,0.00035775194,0.00022753468,0.000097233984,0.0002485903,0.00017188418,0.0000015988305],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002662249,0.00020515938,0.97403294,0.00014774648,0.00015835122,0.000012568909,0.0033790763,0.000015859896,0.00040268232,0.0022008284,0.008832232,0.010346314],"study_design_scores_gemma":[0.010684034,0.0011908012,0.3122191,0.0032183735,0.00038813468,0.000017033057,0.01773969,0.0044140057,0.012484514,0.00039191087,0.63670546,0.00054696406],"about_ca_topic_score_codex":0.010134248,"about_ca_topic_score_gemma":0.026915777,"teacher_disagreement_score":0.66181386,"about_ca_system_score_codex":0.0014394413,"about_ca_system_score_gemma":0.0006297652,"threshold_uncertainty_score":0.99645734},"labels":[],"label_agreement":null},{"id":"W4213132440","doi":"10.1016/j.ctarc.2022.100534","title":"Integrating comprehensive genomic sequencing of non-small cell lung cancer into a public healthcare system","year":2022,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"William Osler Health System; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"KRAS; Medicine; Reimbursement; Clinical trial; Lung cancer; Oncology; Internal medicine; Targeted therapy; Cancer; Bioinformatics; Health care; Biology; Colorectal cancer","score_opus":0.13422541032650281,"score_gpt":0.45275745784603594,"score_spread":0.3185320475195331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213132440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87692374,0.10481908,0.000048009362,0.012419014,0.00011361942,0.00225625,0.00029811307,0.000055314737,0.003066859],"genre_scores_gemma":[0.97926646,0.012548518,0.0019444603,0.00008176026,0.000049797916,0.0050218655,0.00020628105,0.000031235846,0.0008496371],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99834704,0.00039068834,0.00032928717,0.000299417,0.0002801802,0.00035336125],"domain_scores_gemma":[0.9978125,0.00027370473,0.00014105719,0.0009397976,0.0006168704,0.00021604578],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00024029438,0.0001650714,0.0003502368,0.000327087,0.0016941662,0.00003941051,0.00031310652,0.00004351995,0.00006362412],"category_scores_gemma":[0.000010353817,0.00013354036,0.000092153095,0.0005989173,0.00023562371,0.00006597516,0.00045834694,0.00040577503,0.0000014751769],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050699676,0.0028900101,0.53060645,0.0067752027,0.0059642913,0.00008293272,0.17431459,0.00080999645,0.09750562,0.015363082,0.0028408389,0.16234],"study_design_scores_gemma":[0.031279836,0.008905134,0.07637063,0.0052950727,0.005076615,0.00023793778,0.6072406,0.08982459,0.011084324,0.00044570872,0.16245466,0.0017849116],"about_ca_topic_score_codex":0.03807127,"about_ca_topic_score_gemma":0.0035940823,"teacher_disagreement_score":0.45423582,"about_ca_system_score_codex":0.0063319416,"about_ca_system_score_gemma":0.0030098974,"threshold_uncertainty_score":0.9996055},"labels":[],"label_agreement":null},{"id":"W4225121752","doi":"10.1016/j.ctarc.2022.100570","title":"Clinicopathological features of pulmonary mucinous adenocarcinoma: A descriptive analysis","year":2022,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Adenocarcinoma; Stage (stratigraphy); Internal medicine; Radiation therapy; Gastroenterology; Chemotherapy; Oncology; Lung cancer; Cancer; Population","score_opus":0.17980047877639949,"score_gpt":0.4549861908577606,"score_spread":0.2751857120813611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225121752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8377108,0.14314196,0.000003829278,0.011373381,0.000043818898,0.0010815655,0.00030991915,0.000035201967,0.0062995283],"genre_scores_gemma":[0.96229666,0.033183116,0.00035358424,0.000048134174,0.000027487951,0.0024248846,0.00018028243,0.000011229938,0.0014746288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983689,0.0005014709,0.00023101408,0.00031235086,0.00033483683,0.00025143247],"domain_scores_gemma":[0.99801993,0.00041171236,0.00007322403,0.0011403237,0.00020976721,0.0001450403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004018629,0.00012302176,0.0004014488,0.0003767653,0.00075117283,0.00001557257,0.00025957826,0.00004181243,0.0002627565],"category_scores_gemma":[0.000029815474,0.00008800508,0.00020913378,0.0010656769,0.00047002148,0.00003310822,0.00049766,0.00032773535,0.0000019503655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039440568,0.004014176,0.9595305,0.000034101813,0.0018595719,0.00007752124,0.003154769,0.00002651351,0.00024381863,0.0012499894,0.0008004637,0.028614195],"study_design_scores_gemma":[0.0016055923,0.0020785916,0.9819036,0.00003628258,0.0021553864,0.000052355885,0.0038414926,0.00028952325,0.00030206057,0.00021094608,0.007418673,0.000105453546],"about_ca_topic_score_codex":0.0023291698,"about_ca_topic_score_gemma":0.00031504306,"teacher_disagreement_score":0.124585845,"about_ca_system_score_codex":0.0009983783,"about_ca_system_score_gemma":0.00032468067,"threshold_uncertainty_score":0.577749},"labels":[],"label_agreement":null},{"id":"W4225264047","doi":"10.1016/j.ctarc.2022.100557","title":"How well do European patients understand cancer-associated thrombosis? A patient survey","year":2022,"lang":"en","type":"review","venue":"Cancer Treatment and Research Communications","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Medicine; Cancer; Thrombosis; Psychological intervention; MEDLINE; Family medicine; Intensive care medicine; Nursing; Internal medicine","score_opus":0.414638465832463,"score_gpt":0.4783249374725145,"score_spread":0.06368647164005148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225264047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005489962,0.9844937,3.2704244e-7,0.0014013924,0.00016825592,0.0036093402,0.0011305412,0.000056035533,0.008591446],"genre_scores_gemma":[0.0040322873,0.9878205,0.000017900878,0.00005922512,0.00005197277,0.0030062771,0.003279129,0.0001172537,0.0016154241],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943005,0.0032829116,0.00047245107,0.0006334695,0.0006904715,0.00062022853],"domain_scores_gemma":[0.99609524,0.0009305738,0.00032640624,0.001985999,0.00034678922,0.00031497583],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00096032483,0.0004647339,0.0015734172,0.00043618082,0.001426336,0.00027695304,0.0006834581,0.00012885068,0.0005009155],"category_scores_gemma":[0.00016297399,0.0003439961,0.00032638677,0.00096623355,0.00041998713,0.00008421237,0.0013170369,0.00077247294,0.000021975036],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014450773,0.003986483,0.0019087112,0.001476204,0.0032190748,0.00000698608,0.0010433873,3.152172e-7,9.41253e-8,0.00016443356,0.020807205,0.96737266],"study_design_scores_gemma":[0.0010795861,0.0010051838,0.0048677833,0.003400978,0.001782086,6.8982047e-7,0.00057728734,0.000002813672,2.5087363e-7,0.000014346894,0.98697954,0.00028943177],"about_ca_topic_score_codex":0.0044506355,"about_ca_topic_score_gemma":0.0028056111,"teacher_disagreement_score":0.9670832,"about_ca_system_score_codex":0.0037855909,"about_ca_system_score_gemma":0.0008071142,"threshold_uncertainty_score":0.9999012},"labels":[],"label_agreement":null},{"id":"W4281722752","doi":"10.1016/j.ctarc.2022.100585","title":"Treatment patterns and survival outcomes of early-onset colorectal cancer patients in Alberta, Canada: a population-based study","year":2022,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of British Columbia; Alberta Health Services","funders":"Canadian Institutes of Health Research","keywords":"Colorectal cancer; Medicine; Demography; Cancer; Oncology; Population; Internal medicine; Gerontology; Environmental health; Sociology","score_opus":0.07038987003829185,"score_gpt":0.3882815592961511,"score_spread":0.31789168925785927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281722752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957907,0.00063989,2.350909e-7,0.0018642611,0.000065806715,0.001231193,0.00031482993,0.0000092345035,0.00008382896],"genre_scores_gemma":[0.9960337,0.00062108185,0.000010857011,0.000014239291,0.000009846129,0.0028749122,0.0001472513,0.0000138260975,0.00027424132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985541,0.00040890183,0.00023040577,0.00023613295,0.0003582138,0.00021225815],"domain_scores_gemma":[0.9987554,0.0005534511,0.00006634618,0.0003896507,0.0001266768,0.00010847695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014996536,0.00013145697,0.00032345566,0.00021367194,0.00047758987,0.000014077835,0.0001097282,0.000025255204,0.00005329695],"category_scores_gemma":[0.000033599037,0.000104939085,0.000037901824,0.0003502477,0.000064035914,0.000031197174,0.00014368493,0.00017516916,1.10886724e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009194598,0.0013113596,0.9877546,0.000010984773,0.00016204394,0.0000024670435,0.0014651662,0.000040208706,0.000003386575,0.000004733861,0.000008779756,0.008316803],"study_design_scores_gemma":[0.0041713435,0.0056523546,0.98818207,0.000021752005,0.00008083172,7.1729744e-7,0.0010538005,0.00045540297,0.000049291088,0.0000043941827,0.00024599856,0.00008204747],"about_ca_topic_score_codex":0.9896014,"about_ca_topic_score_gemma":0.99176985,"teacher_disagreement_score":0.008234755,"about_ca_system_score_codex":0.0023484891,"about_ca_system_score_gemma":0.00095830363,"threshold_uncertainty_score":0.61412174},"labels":[],"label_agreement":null},{"id":"W4282596597","doi":"10.1016/j.ctarc.2022.100592","title":"Interaction between tumor microenvironment, autophagy, and epithelial-mesenchymal transition in tumor progression","year":2022,"lang":"en","type":"review","venue":"Cancer Treatment and Research Communications","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Autophagy; Tumor microenvironment; Metastasis; Cancer research; Carcinogenesis; Epithelial–mesenchymal transition; Tumor progression; Biology; Mechanism (biology); Tumor cells; Apoptosis; Cancer","score_opus":0.19836602034884418,"score_gpt":0.4991227410702917,"score_spread":0.30075672072144755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282596597","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0104238,0.985944,9.503446e-7,0.0007462212,0.000036490317,0.0022027483,0.00030941528,0.000028799614,0.000307593],"genre_scores_gemma":[0.0066951937,0.9881922,0.000106593216,0.000028481349,0.00010753443,0.0035862976,0.0009415949,0.000043950706,0.0002981599],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99778384,0.00083145796,0.0004016969,0.00040880786,0.00025959185,0.00031462588],"domain_scores_gemma":[0.9983067,0.00048060072,0.00013410243,0.0008584898,0.000026608746,0.0001934876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004028672,0.0002760659,0.00080241094,0.0004534864,0.0005329714,0.00004590249,0.00022815843,0.00008877725,0.00031266132],"category_scores_gemma":[0.000019374493,0.00020577172,0.00015974515,0.000360698,0.00040680775,0.00009871389,0.00023861417,0.00077780837,0.000010253883],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060654744,0.00057847355,0.00029465786,0.001496147,0.00027870387,0.0000446236,0.000627605,1.4217997e-7,0.000022720697,0.000030650554,0.000050192237,0.99651545],"study_design_scores_gemma":[0.0012227009,0.0005656658,0.0012130137,0.004813724,0.00060733984,0.00005875841,0.00028857368,0.000029618323,0.000045679055,0.00006164661,0.9909237,0.00016959423],"about_ca_topic_score_codex":0.00031820193,"about_ca_topic_score_gemma":0.00004418864,"teacher_disagreement_score":0.9963458,"about_ca_system_score_codex":0.001060696,"about_ca_system_score_gemma":0.0004601203,"threshold_uncertainty_score":0.8391127},"labels":[],"label_agreement":null},{"id":"W4292640845","doi":"10.1016/j.ctarc.2022.100625","title":"Exploring the prognostic impact of tumor sidedness in ovarian cancer: A population-based survival analysis of over 10,000 patients","year":2022,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Proportional hazards model; Internal medicine; Survival analysis; Ovarian cancer; Population; Log-rank test; Cohort; Cancer; Oncology; Gynecology; Gastroenterology; Surgery","score_opus":0.22223543453226452,"score_gpt":0.4443921806036002,"score_spread":0.22215674607133568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292640845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938241,0.0027971098,6.365313e-7,0.0014786695,0.000036295492,0.0009935003,0.00071139005,0.0000062443846,0.00015200458],"genre_scores_gemma":[0.9922946,0.0024111965,0.00003278768,0.000011237497,0.000012670144,0.00478267,0.00038254168,0.000014162102,0.00005811341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832326,0.0004797699,0.00033029678,0.00021220955,0.00042388623,0.00023057843],"domain_scores_gemma":[0.99770665,0.0008847096,0.00013368987,0.00093899784,0.0002498776,0.00008606547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038875887,0.0001246167,0.00041311124,0.0005803748,0.00036565273,0.0000146546245,0.00023717106,0.000015123948,0.0005909813],"category_scores_gemma":[0.000064908854,0.00008107361,0.00018807244,0.0020882033,0.0001545875,0.00006186765,0.0001695697,0.00017085765,2.6315277e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024983348,0.0018536021,0.9863167,0.000026503682,0.0015744279,0.0000018953074,0.00095185195,0.0032119153,0.00002602821,0.00013861395,0.00002767459,0.005620975],"study_design_scores_gemma":[0.0024734023,0.0006912733,0.9927273,0.00008744912,0.00090575696,1.4826038e-7,0.0003032657,0.0024682889,0.000057423378,0.000018230086,0.00020460966,0.00006284442],"about_ca_topic_score_codex":0.10746698,"about_ca_topic_score_gemma":0.009686841,"teacher_disagreement_score":0.09778014,"about_ca_system_score_codex":0.0015823147,"about_ca_system_score_gemma":0.00063019205,"threshold_uncertainty_score":0.8984765},"labels":[],"label_agreement":null},{"id":"W4306682001","doi":"10.1016/j.ctarc.2022.100652","title":"The impact of frailty on health outcomes in older adults with lung cancer: A systematic review","year":2022,"lang":"en","type":"review","venue":"Cancer Treatment and Research Communications","topic":"Frailty in Older Adults","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lung cancer; Hazard ratio; Quality of life (healthcare); Gerontology; Population; Discontinuation; Cancer; Internal medicine; Confidence interval","score_opus":0.21127210852302403,"score_gpt":0.5519309706629966,"score_spread":0.34065886213997254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306682001","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025181063,0.9777395,1.14593355e-7,0.0076768175,0.000022383843,0.013812588,0.00038690373,0.00001717531,0.00031931186],"genre_scores_gemma":[0.0001770621,0.97228616,0.000018945508,0.00005326619,0.000013568093,0.025490956,0.0002531291,0.000050369552,0.0016565195],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9956866,0.0019896606,0.0009041077,0.00035496202,0.00059667055,0.00046802108],"domain_scores_gemma":[0.99253243,0.0034234317,0.00050309836,0.0031404463,0.00019884866,0.00020176545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011593379,0.0003800313,0.0028354626,0.00031867553,0.00059169193,0.000028986076,0.00079334085,0.000079811245,0.00011095405],"category_scores_gemma":[0.00031118013,0.00016597599,0.00040566057,0.0010269302,0.000375594,0.00003621827,0.00028617017,0.00096468464,0.0000025846955],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049607752,0.0007585539,0.0006122332,0.6379373,0.0018762143,0.0000048710904,0.0010288896,7.953628e-7,4.9994107e-9,0.000043062915,0.0021631683,0.35552529],"study_design_scores_gemma":[0.0015029168,0.0012382395,0.0004776621,0.89840263,0.0012224653,0.000019462112,0.00026340727,0.000029212457,3.991031e-8,0.000002681042,0.0966837,0.0001575851],"about_ca_topic_score_codex":0.013359131,"about_ca_topic_score_gemma":0.005689872,"teacher_disagreement_score":0.35536772,"about_ca_system_score_codex":0.004404646,"about_ca_system_score_gemma":0.0038259767,"threshold_uncertainty_score":0.99941725},"labels":[],"label_agreement":null},{"id":"W4309731105","doi":"10.1016/j.ctarc.2022.100662","title":"A reduced dosing strategy can work for Alectinib in ALK rearranged non small cell lung cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Alectinib; Dosing; Lung cancer; Medicine; Cancer; Crizotinib; Oncology; Intensive care medicine; Internal medicine","score_opus":0.14559758084820454,"score_gpt":0.47367715177419567,"score_spread":0.32807957092599116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309731105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91815716,0.047204588,0.000012145089,0.018832035,0.00012749873,0.0046203607,0.0003753389,0.00004931776,0.01062154],"genre_scores_gemma":[0.9625299,0.011699175,0.0006596172,0.00008877488,0.00007043618,0.016815776,0.0003121132,0.000037889513,0.007786316],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985228,0.00023750094,0.0002371816,0.00034535246,0.0002071085,0.00045002036],"domain_scores_gemma":[0.99846715,0.00033220544,0.00006572972,0.0007714047,0.00019275416,0.00017074704],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00032323884,0.00016242774,0.00026878752,0.00030540433,0.0013022812,0.000054302756,0.00023284732,0.000050132894,0.00012674918],"category_scores_gemma":[0.000018141387,0.00013958155,0.00008045602,0.00082083675,0.00014268544,0.00004604876,0.00016390297,0.00037316393,6.675963e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034188926,0.009027021,0.47384533,0.0008368339,0.0029478967,0.00007405883,0.08274816,0.0023380003,0.03813153,0.0008413808,0.018476646,0.36731425],"study_design_scores_gemma":[0.0924567,0.01067004,0.34072798,0.002975422,0.005241143,0.00007130412,0.05535157,0.013439337,0.016306026,0.0014087289,0.45895478,0.0023969798],"about_ca_topic_score_codex":0.013374324,"about_ca_topic_score_gemma":0.008402599,"teacher_disagreement_score":0.44047812,"about_ca_system_score_codex":0.0023542948,"about_ca_system_score_gemma":0.00160853,"threshold_uncertainty_score":0.9999979},"labels":[],"label_agreement":null},{"id":"W4313368242","doi":"10.1016/j.ctarc.2022.100678","title":"A study of the efficacy and toxicity outcomes of extended durvalumab dosing in patients with stage III unresectable non-small cell lung cancer (NSCLC) during the COVID-19 pandemic","year":2022,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre; Princess Margaret Cancer Centre; Queen's University; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Dosing; Medicine; Durvalumab; Discontinuation; Toxicity; Lung cancer; Internal medicine; Adverse effect; Retrospective cohort study; Stage (stratigraphy); Cancer; Surgery; Oncology; Immunotherapy; Nivolumab","score_opus":0.08383939205344686,"score_gpt":0.41299750268721486,"score_spread":0.329158110633768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313368242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988253,0.006342037,3.9344377e-7,0.001632297,0.000020616377,0.0034699538,0.00011439314,0.000008062709,0.00015927333],"genre_scores_gemma":[0.99200207,0.0047782497,0.000014105436,0.00004034739,0.000006073236,0.0026301981,0.000010282787,0.000015951267,0.0005027422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828285,0.00052299973,0.00026520615,0.00025576982,0.00042139261,0.00025176033],"domain_scores_gemma":[0.9978717,0.00065809896,0.0001399292,0.0010991041,0.0001275844,0.00010357386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042239297,0.00014405209,0.00033696645,0.00013633315,0.0010087624,0.000018906085,0.00032923164,0.00002439815,0.00004388498],"category_scores_gemma":[0.000032728258,0.00007389849,0.000043512147,0.00051788846,0.00030516394,0.000039536346,0.00063057104,0.00030250792,5.2123635e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063039816,0.004233706,0.98208785,0.00012195861,0.00040488798,0.000001960703,0.011648773,0.00028843628,0.00011804693,0.00000942285,0.000020420981,0.00043412708],"study_design_scores_gemma":[0.019764178,0.0011078573,0.9739772,0.0001160164,0.00023096782,9.467534e-7,0.0042191967,0.00007666366,0.0002912883,0.0000034442287,0.00014207952,0.00007014209],"about_ca_topic_score_codex":0.019897642,"about_ca_topic_score_gemma":0.016923096,"teacher_disagreement_score":0.019133778,"about_ca_system_score_codex":0.0017046232,"about_ca_system_score_gemma":0.0006843556,"threshold_uncertainty_score":0.98662895},"labels":[],"label_agreement":null},{"id":"W4317470309","doi":"10.1016/j.ctarc.2023.100683","title":"Real-world treatment outcomes in HR+ HER2- metastatic breast cancer patients treated with CDK4/6 inhibitors: Results from a reference center in Brazil","year":2023,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Discontinuation; Internal medicine; Tolerability; Palbociclib; Neutropenia; Adverse effect; Breast cancer; Metastatic breast cancer; Gastroenterology; Oncology; Febrile neutropenia; Population; Cancer; Chemotherapy","score_opus":0.12236005037989336,"score_gpt":0.4448572747629137,"score_spread":0.3224972243830203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317470309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97928655,0.0012775573,2.4827094e-7,0.013480107,0.000032138312,0.0017250584,0.0028736715,0.00010348176,0.0012211805],"genre_scores_gemma":[0.9599045,0.031377587,0.00026768973,0.000053906253,0.00003918823,0.0033835438,0.0014780754,0.00005666325,0.0034388811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729985,0.00042688166,0.00053689594,0.0006253626,0.00043863995,0.00067235966],"domain_scores_gemma":[0.9972437,0.0007291593,0.00012712738,0.0013548741,0.00030058008,0.00024458425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022859326,0.0003671239,0.00066549535,0.00086003426,0.0002690401,0.000053814412,0.0002900218,0.00007063354,0.00007430273],"category_scores_gemma":[0.00003228012,0.00024026861,0.0000675152,0.0018406241,0.00048245428,0.000214705,0.0001802466,0.00034960156,0.000024087325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022514374,0.0023810188,0.9433503,0.00002304903,0.00045101426,0.00003817418,0.0030428735,0.00003096735,0.00014957086,0.0000369992,0.000104163424,0.04814039],"study_design_scores_gemma":[0.0190358,0.0007692844,0.97107404,0.0009284664,0.00009995203,0.0000025478082,0.00083196757,0.00015988262,0.00029040297,0.00009580205,0.00648171,0.0002301215],"about_ca_topic_score_codex":0.15041296,"about_ca_topic_score_gemma":0.23907973,"teacher_disagreement_score":0.08866677,"about_ca_system_score_codex":0.0031751837,"about_ca_system_score_gemma":0.00052027614,"threshold_uncertainty_score":0.97978693},"labels":[],"label_agreement":null},{"id":"W4327703589","doi":"10.1016/j.ctarc.2023.100696","title":"Next-generation sequencing of non-small cell lung cancer at a Quebec health care cancer centre","year":2023,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill Genome Centre; McGill University; McGill University Health Centre","funders":"","keywords":"KRAS; Lung cancer; Medicine; Cancer; Oncology; Internal medicine; Cohort; Clinical trial; Targeted therapy; Bioinformatics; Biology; Colorectal cancer","score_opus":0.1813665434080559,"score_gpt":0.46875777750188424,"score_spread":0.28739123409382833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327703589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8364461,0.13885057,0.000008448507,0.019921416,0.00014953934,0.0021788138,0.00057638553,0.00007955767,0.0017891374],"genre_scores_gemma":[0.8297531,0.15084688,0.00038583708,0.00012867738,0.0001506915,0.002179166,0.0008887784,0.000038813832,0.01562804],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99836975,0.00018184389,0.00031783385,0.00035533408,0.00029166974,0.0004835613],"domain_scores_gemma":[0.9979862,0.00015330817,0.00012650152,0.0009108995,0.00054977706,0.00027332746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017382183,0.00019622063,0.00035280417,0.0002992042,0.0010017214,0.000046613102,0.0001950426,0.00008122659,0.00015261577],"category_scores_gemma":[0.000012227322,0.00015408262,0.00009668258,0.0007746599,0.00023029034,0.00010546515,0.00020706607,0.0001909083,0.000009744326],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025942226,0.0010314399,0.38240916,0.002624905,0.0024380113,0.000026727266,0.17996767,0.0012490521,0.07028847,0.00048834604,0.05212499,0.30709183],"study_design_scores_gemma":[0.037047543,0.0033790495,0.22016408,0.008794902,0.005379732,0.000022864182,0.11833707,0.077562094,0.112853356,0.00007972495,0.41414934,0.0022302284],"about_ca_topic_score_codex":0.17844066,"about_ca_topic_score_gemma":0.28081518,"teacher_disagreement_score":0.36202437,"about_ca_system_score_codex":0.0062086927,"about_ca_system_score_gemma":0.004051687,"threshold_uncertainty_score":0.9976063},"labels":[],"label_agreement":null},{"id":"W4384945340","doi":"10.1016/j.ctarc.2023.100746","title":"High tumor mutation burden (TMB) in microsatellite stable (MSS) colorectal cancers: Diverse molecular associations point to variable pathophysiology","year":2023,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Essar Steel Algoma (Canada); Sault Area Hospital","funders":"","keywords":"KRAS; Microsatellite instability; Colorectal cancer; DNA mismatch repair; Cancer research; Mutation; Medicine; Epigenetics; Cancer; Biology; Gene; Internal medicine; Genetics; Microsatellite; Allele","score_opus":0.06664542607681266,"score_gpt":0.392304617592637,"score_spread":0.32565919151582434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384945340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98807335,0.002145891,0.000011561,0.0068394593,0.000119656164,0.0014721667,0.00033858093,0.00006767163,0.00093163905],"genre_scores_gemma":[0.9873947,0.0060232775,0.002576273,0.00016471399,0.00006151623,0.002216084,0.00046228684,0.000029735957,0.0010714496],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99823,0.00034364776,0.00026035885,0.0003639897,0.00027734524,0.0005246629],"domain_scores_gemma":[0.99818176,0.00048302687,0.00005611302,0.00069886626,0.00037477593,0.0002054747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046341022,0.00015991929,0.00031208296,0.00043875337,0.00039589123,0.000048584403,0.00025802388,0.000091743284,0.00013836173],"category_scores_gemma":[0.00022988826,0.00014500791,0.000050244915,0.0016016908,0.00023301078,0.00007160131,0.00035669148,0.00029106135,0.000065480424],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013433621,0.001143563,0.056701,0.0002180658,0.0010589957,0.00030430342,0.02798785,0.012370042,0.84152704,0.003851917,0.008176694,0.045317136],"study_design_scores_gemma":[0.025045149,0.012607292,0.6074669,0.0018026625,0.0009598229,0.00006306943,0.029173994,0.017344775,0.18112706,0.029980477,0.092061885,0.0023669647],"about_ca_topic_score_codex":0.022639606,"about_ca_topic_score_gemma":0.0033491645,"teacher_disagreement_score":0.66040003,"about_ca_system_score_codex":0.002766839,"about_ca_system_score_gemma":0.0009459963,"threshold_uncertainty_score":0.9838687},"labels":[],"label_agreement":null},{"id":"W4385285672","doi":"10.1016/j.ctarc.2023.100747","title":"Survival outcomes and predicting intracranial metastasis in stage III non-small cell lung cancer treated with definitive chemoradiation: Real-world data from a tertiary cancer center","year":2023,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Hamilton Health Sciences; Kingston Health Sciences Centre; Ottawa Hospital; Queen's University","funders":"","keywords":"Medicine; Lung cancer; Center (category theory); Oncology; Stage (stratigraphy); Internal medicine; Tertiary care; Brain metastasis; Distant metastasis; Metastasis; Real world data; Cancer; Biology; Computer science; Chemistry","score_opus":0.17347780638350102,"score_gpt":0.4341727992050757,"score_spread":0.26069499282157466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385285672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780476,0.006700895,0.0000064023943,0.0076054824,0.000040797044,0.001483446,0.0052975537,0.000062343315,0.000755455],"genre_scores_gemma":[0.90168726,0.09105298,0.00071443344,0.00006839199,0.00008077135,0.0019697594,0.0027149904,0.000044428427,0.0016669799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979101,0.00035615658,0.00032770206,0.00059651735,0.0003136281,0.00049594004],"domain_scores_gemma":[0.99717087,0.0009319132,0.00011230629,0.0013716416,0.0001683294,0.00024496342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004720666,0.00028284002,0.0005646352,0.00037807217,0.00045577352,0.00008385067,0.00031366645,0.000055825567,0.00011815633],"category_scores_gemma":[0.000024411167,0.00019399797,0.000048523292,0.0009042332,0.00042437486,0.0001720766,0.0004975879,0.00034463863,0.0000032855485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033367577,0.00057151326,0.9824171,0.00007085997,0.0011334211,0.00007421992,0.001638492,0.000018071676,0.000059358554,0.000019787245,0.00025244566,0.013411076],"study_design_scores_gemma":[0.010416637,0.00020785665,0.97591406,0.0004021211,0.00077158265,0.000001655823,0.002153975,0.008164933,0.00027161022,0.000008087665,0.001487774,0.00019971136],"about_ca_topic_score_codex":0.18253191,"about_ca_topic_score_gemma":0.23923464,"teacher_disagreement_score":0.08435208,"about_ca_system_score_codex":0.00058312144,"about_ca_system_score_gemma":0.0005142834,"threshold_uncertainty_score":0.8229117},"labels":[],"label_agreement":null},{"id":"W4387491491","doi":"10.1016/j.ctarc.2023.100767","title":"The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutations and their influence on the NLR in NSCLC patients treated with immunotherapy","year":2023,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Université de Montréal","keywords":"STK11; KRAS; Immunotherapy; Oncology; Medicine; Internal medicine; Cancer","score_opus":0.07313046330335114,"score_gpt":0.40848728692078057,"score_spread":0.3353568236174294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387491491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98115087,0.012624355,1.5698696e-7,0.0047416086,0.00000448782,0.0011936667,0.000059841146,0.000015493695,0.00020955279],"genre_scores_gemma":[0.9255014,0.07358802,0.000006692541,0.00002468755,0.000004713142,0.0006542871,0.0000403642,0.000012279687,0.00016754521],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990877,0.00024973505,0.00016354684,0.00014320694,0.00014236923,0.00021344282],"domain_scores_gemma":[0.99749744,0.0015934223,0.00005280122,0.00062599935,0.00017756091,0.000052789466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037220202,0.00012085152,0.00015222614,0.00012938268,0.000614949,0.000049991308,0.00015815893,0.000035211713,0.0000073731812],"category_scores_gemma":[0.00005957345,0.00004967597,0.000035231405,0.00070325204,0.0010742124,0.0000514721,0.000058980557,0.00017023523,8.9440135e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001543323,0.0004111681,0.90630853,0.000017016104,0.00050200766,0.0000011670643,0.005101783,0.0000075458456,0.0020732393,0.0002033303,0.00012322309,0.08370766],"study_design_scores_gemma":[0.0026416827,0.0017436536,0.992476,0.00021305124,0.00002420355,0.0000022132544,0.0011973688,0.00022510307,0.00025386538,0.000101091384,0.0010640565,0.00005772933],"about_ca_topic_score_codex":0.003592825,"about_ca_topic_score_gemma":0.001457049,"teacher_disagreement_score":0.08616744,"about_ca_system_score_codex":0.00017951711,"about_ca_system_score_gemma":0.00021481211,"threshold_uncertainty_score":0.54313004},"labels":[],"label_agreement":null},{"id":"W4388343130","doi":"10.1016/j.ctarc.2023.100774","title":"Presentation and outcomes of KRASG12C mutant non-small cell lung cancer patients with stage IV disease at diagnosis (de novo) versus at recurrence","year":2023,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; McMaster University; Dalhousie University; University of Toronto; University Health Network","funders":"Amgen Canada","keywords":"Medicine; Hazard ratio; Internal medicine; Stage (stratigraphy); Oncology; Targeted therapy; Progressive disease; Lung cancer; Cancer; Disease; Gastroenterology; Confidence interval","score_opus":0.0782646992820013,"score_gpt":0.4428730312875759,"score_spread":0.3646083320055746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388343130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98576266,0.007239641,0.000001890853,0.003725465,0.000054952103,0.0016196702,0.0009819259,0.000030556002,0.00058325456],"genre_scores_gemma":[0.9256586,0.066423416,0.00014505537,0.000018746172,0.000016357324,0.0034214759,0.000540631,0.000024381492,0.0037513566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987766,0.000109707646,0.00019201996,0.00029555702,0.00029752147,0.00032858664],"domain_scores_gemma":[0.99800915,0.0006053781,0.00008893892,0.00068412453,0.00030548766,0.0003069132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001101761,0.00016741124,0.00024242571,0.00019336461,0.000605338,0.000026608774,0.00014326916,0.00004320259,0.00008021301],"category_scores_gemma":[0.000042157943,0.000115677976,0.000048481732,0.00044311746,0.00035071367,0.00010449039,0.00027976127,0.00011135041,0.000005311264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059487246,0.00062226347,0.99142045,0.00019363465,0.00044531422,0.000007425147,0.002825334,0.00003060269,0.00011840231,0.000041372637,0.00034423076,0.0033561077],"study_design_scores_gemma":[0.00778177,0.00052799797,0.9849575,0.00024405796,0.0006780381,2.9667186e-7,0.0003828248,0.0005852066,0.00081872486,0.0000082696815,0.0038927905,0.00012252395],"about_ca_topic_score_codex":0.0029891813,"about_ca_topic_score_gemma":0.0037870833,"teacher_disagreement_score":0.06010406,"about_ca_system_score_codex":0.0011973118,"about_ca_system_score_gemma":0.0004842426,"threshold_uncertainty_score":0.4717211},"labels":[],"label_agreement":null},{"id":"W4402933007","doi":"10.1016/j.ctarc.2024.100846","title":"Low to intermediate grade lung neuroendocrine tumours. A single centre real world experience","year":2024,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Neuroendocrine tumour; Lung; Medicine; Pathology; Internal medicine","score_opus":0.10716445222904525,"score_gpt":0.4641708018772585,"score_spread":0.35700634964821326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402933007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89250636,0.015777892,0.0000054348984,0.08317685,0.00019397507,0.0018705194,0.00008274069,0.00026658422,0.0061196475],"genre_scores_gemma":[0.95218045,0.025807485,0.0003001655,0.000115067865,0.00013780194,0.0010318101,0.00004545536,0.000044631975,0.02033714],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99781954,0.00026971143,0.00023685081,0.0004890255,0.00045832875,0.0007265552],"domain_scores_gemma":[0.9973689,0.0005867156,0.000019818823,0.0012309982,0.00018816371,0.0006054175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010872955,0.0001984807,0.00025691942,0.0006528067,0.000381601,0.00019817357,0.00046439946,0.0000059151703,0.0001612358],"category_scores_gemma":[0.00014762192,0.00015079005,0.000079146914,0.001247771,0.00059111055,0.00019170069,0.00063671434,0.00049553165,0.000060144448],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021209072,0.009969909,0.24227224,0.0024555554,0.0011889475,0.01955233,0.025397666,0.000048037175,0.16449058,0.01301932,0.09210555,0.42737895],"study_design_scores_gemma":[0.0040777973,0.003654751,0.040847145,0.0036119819,0.00023658294,0.0007015625,0.0042928467,0.0043648975,0.112604156,0.00061822677,0.8242344,0.00075565436],"about_ca_topic_score_codex":0.0008336194,"about_ca_topic_score_gemma":0.0031091957,"teacher_disagreement_score":0.73212886,"about_ca_system_score_codex":0.0007123052,"about_ca_system_score_gemma":0.00029920036,"threshold_uncertainty_score":0.614904},"labels":[],"label_agreement":null},{"id":"W4408348828","doi":"10.1016/j.ctarc.2025.100896","title":"Real-world evaluation of treatment patterns and clinical outcomes in patients with BRAF-V600E metastatic colorectal cancer (mCRC) in Canada","year":2025,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Electricity Association; Ottawa Hospital; University of Ottawa","funders":"Pfizer Canada","keywords":"Colorectal cancer; Medicine; Oncology; Internal medicine; Cancer","score_opus":0.15642130535958787,"score_gpt":0.4939102658841411,"score_spread":0.33748896052455324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408348828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989912,0.003995431,1.5198488e-7,0.0027120092,0.00004300283,0.001989855,0.00018878702,0.000005410082,0.00115338],"genre_scores_gemma":[0.9640649,0.033429395,0.000059022244,0.000023878023,0.0000059981376,0.0019548736,0.00007201466,0.000010188908,0.00037973226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982287,0.00044259988,0.00041361517,0.00030100593,0.0003444036,0.00026963616],"domain_scores_gemma":[0.99825835,0.00072090124,0.00008094884,0.00046056,0.00038407245,0.00009515963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038526635,0.0001829887,0.0005874703,0.00033306563,0.0001620823,0.000014154669,0.000103830826,0.000029950425,0.000037183014],"category_scores_gemma":[0.000052246047,0.00011575612,0.00004478114,0.00053108,0.00026850268,0.000052981984,0.00011902293,0.0001553019,1.6607896e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004785327,0.0010809624,0.9163721,0.00003115861,0.0008363684,0.000002456621,0.0004640504,0.000012398807,0.0000019769907,0.00004711168,0.000023162793,0.08064972],"study_design_scores_gemma":[0.010696011,0.0012427217,0.9857024,0.00029511537,0.0005085526,1.7970595e-7,0.0006770458,0.00041900115,0.000039415798,0.00003505538,0.00030142657,0.00008308958],"about_ca_topic_score_codex":0.9475211,"about_ca_topic_score_gemma":0.9976283,"teacher_disagreement_score":0.08056663,"about_ca_system_score_codex":0.006291187,"about_ca_system_score_gemma":0.0041912496,"threshold_uncertainty_score":0.9975235},"labels":[],"label_agreement":null},{"id":"W4413439314","doi":"10.1016/j.ctarc.2025.100982","title":"Impact of adjuvant therapy on survival in treatment of CNS hemangiopericytomas","year":2025,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"","keywords":"Hemangiopericytoma; Adjuvant therapy; Medicine; Adjuvant; Oncology; Internal medicine; Chemotherapy; Radiology","score_opus":0.244250553721533,"score_gpt":0.5373752427245475,"score_spread":0.29312468900301447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413439314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93245935,0.05864587,3.996668e-7,0.0024541658,0.000016820393,0.0007484279,0.000048668004,0.00001021095,0.005616095],"genre_scores_gemma":[0.8808335,0.11744381,0.00006527807,0.0000042313964,0.000011125514,0.00041098343,0.000019464811,0.0000073277547,0.0012042997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991655,0.00017160954,0.00019941466,0.00014202124,0.00014273438,0.00017872445],"domain_scores_gemma":[0.99825865,0.0005815509,0.0000366307,0.0008824417,0.00018900113,0.000051732855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013890928,0.00011398354,0.00039973247,0.00033824623,0.000111183894,0.000004387464,0.00011322689,0.00003098003,0.000032346252],"category_scores_gemma":[0.000042705986,0.000069767884,0.000112431495,0.00054725667,0.0004286424,0.00001782771,0.000064869026,0.000071791736,0.0000014716195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011283295,0.0050925063,0.85044986,0.000046488934,0.0013155226,0.0000139633685,0.0057694893,0.000009640391,0.004620675,0.001243498,0.00020780247,0.1301022],"study_design_scores_gemma":[0.005754282,0.00608028,0.9765678,0.0003071214,0.00006848019,0.0000019879146,0.0008700069,0.00006020158,0.0061450005,0.00010629197,0.0039763744,0.00006216849],"about_ca_topic_score_codex":0.007934039,"about_ca_topic_score_gemma":0.0011172196,"teacher_disagreement_score":0.13004003,"about_ca_system_score_codex":0.000748256,"about_ca_system_score_gemma":0.0004070993,"threshold_uncertainty_score":0.9986722},"labels":[],"label_agreement":null},{"id":"W4415306169","doi":"10.1016/j.ctarc.2025.101021","title":"Retrospective database analysis to assess treatment patterns, clinical outcomes, and healthcare resource utilization in metastatic or recurrent HER2-positive breast cancer in Alberta","year":2025,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); Alberta Cancer Foundation; University of Calgary; Foothills Medical Centre","funders":"AstraZeneca","keywords":"Metastatic breast cancer; Breast cancer; Recurrent breast cancer; Health care; Medical diagnosis; Retrospective cohort study; Cancer treatment","score_opus":0.37454311074845226,"score_gpt":0.5960753306706257,"score_spread":0.22153221992217342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415306169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75041527,0.023940317,0.00010499173,0.21240044,0.00011443611,0.007482041,0.00435,0.000043416458,0.001149109],"genre_scores_gemma":[0.8748065,0.11870461,0.00025200128,0.00025033523,0.000025803325,0.0032327697,0.00047694292,0.000022438257,0.002228609],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958793,0.0017706485,0.00062834664,0.0007398543,0.0004323132,0.0005495739],"domain_scores_gemma":[0.9960291,0.0015960789,0.000075266245,0.0014867657,0.00041880997,0.0003940029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012061538,0.00025779064,0.0008266841,0.0012461318,0.00031496066,0.00008196995,0.0003042403,0.00009761664,0.00011992616],"category_scores_gemma":[0.00031160403,0.00018181698,0.000105885796,0.0030386709,0.0003366655,0.00009763055,0.0004308473,0.00055780984,0.0000027306314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008154924,0.0013524299,0.88273335,0.00009703571,0.0011042121,0.000022626327,0.0014969528,0.000009851725,0.0000045514157,0.00042518307,0.00017670025,0.11176163],"study_design_scores_gemma":[0.0032894476,0.0009070629,0.98593915,0.0010154761,0.0004827926,0.0000033462902,0.0014550508,0.00149042,0.000028277778,0.000035389912,0.00521054,0.0001430283],"about_ca_topic_score_codex":0.18053855,"about_ca_topic_score_gemma":0.6380293,"teacher_disagreement_score":0.45749074,"about_ca_system_score_codex":0.0046421853,"about_ca_system_score_gemma":0.0016569679,"threshold_uncertainty_score":0.9991788},"labels":[],"label_agreement":null},{"id":"W4416426290","doi":"10.1016/j.ctarc.2025.101040","title":"Artificial intelligence in Glioblastoma Diagnostics: Integrating MRI, histopathology, and molecular profiling","year":2025,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute for Genetic Engineering and Biotechnology","keywords":"Workflow; Profiling (computer programming); Glioblastoma; Precision medicine; Applications of artificial intelligence; Molecular diagnostics","score_opus":0.08045639848709268,"score_gpt":0.43916104033496267,"score_spread":0.35870464184787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416426290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90140414,0.07184727,0.0001536396,0.023397932,0.00004093696,0.0010933026,0.000016789612,0.000028540733,0.0020174708],"genre_scores_gemma":[0.9537294,0.042259127,0.0026291893,0.00007185111,0.000012034965,0.0012055986,0.000015788468,0.000008142725,0.00006887134],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901056,0.00018506423,0.00022192072,0.00024957213,0.00009869918,0.00023418533],"domain_scores_gemma":[0.9985164,0.0006638128,0.000026403559,0.00056263903,0.00014502602,0.00008574389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028812076,0.00011589422,0.000208986,0.0003891792,0.00028657538,0.000041820313,0.00012035354,0.00006549635,0.000009478863],"category_scores_gemma":[0.00024292766,0.00008912167,0.000032438245,0.00046788465,0.00046937403,0.000037379225,0.00021172046,0.00024197742,0.0000029393289],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020322642,0.0022714902,0.32121673,0.00011598594,0.00017422636,0.00019441717,0.002140321,0.00001442784,0.012255504,0.124827586,0.00016653982,0.5364195],"study_design_scores_gemma":[0.007954087,0.008884842,0.22510266,0.008751854,0.0015797731,0.00021743556,0.026974889,0.04100179,0.5422129,0.09872695,0.03713246,0.0014603774],"about_ca_topic_score_codex":0.0007783819,"about_ca_topic_score_gemma":0.0018200716,"teacher_disagreement_score":0.53495914,"about_ca_system_score_codex":0.0004029167,"about_ca_system_score_gemma":0.00020084981,"threshold_uncertainty_score":0.3634276},"labels":[],"label_agreement":null}]}